{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:33:16Z","timestamp":1793323996434,"version":"4.5.0"},"reference-count":212,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82372760"],"award-info":[{"award-number":["82372760"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82103291"],"award-info":[{"award-number":["82103291"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shandong Provincal Natural Science Foundation","award":["ZR2022LZL002"],"award-info":[{"award-number":["ZR2022LZL002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02467-8","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:41:07Z","timestamp":1759491667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Non-coding RNAs in gastric cancer: mechanisms and therapeutic prospects"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhifei","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yigao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinggang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyue","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houbao","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasha","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"2467_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"2467_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S2468-1253(19)30328-0","volume":"5","author":"GBD 2017 Stomach Cancer Collaborators","year":"2020","unstructured":"GBD 2017 Stomach Cancer Collaborators. The global, regional, and national burden of stomach cancer in 195 countries, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2020;5:42\u201354. https:\/\/doi.org\/10.1016\/S2468-1253(19)30328-0.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2467_CR3","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.7150\/thno.85592","volume":"13","author":"W Zhang","year":"2023","unstructured":"Zhang W, Ding X, Cheng H, Yin C, Yan J, Mou Z, Wang W, Cui D, Fan C, Sun D. Erratum: Dual-Targeted gold nanoprism for recognition of early apoptosis, Dual-Model imaging and precise cancer photothermal therapy: erratum. Theranostics. 2023;13:2964\u20135. https:\/\/doi.org\/10.7150\/thno.85592.","journal-title":"Theranostics"},{"key":"2467_CR4","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.cgh.2017.05.023","volume":"15","author":"M Rugge","year":"2017","unstructured":"Rugge M, Genta RM, Di Mario F, El-Omar EM, El-Serag HB, Fassan M, et al. Gastric cancer as preventable disease. Clin Gastroenterol Hepatol. 2017;15:1833\u201343. https:\/\/doi.org\/10.1016\/j.cgh.2017.05.023.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2467_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/cam4.1274","volume":"7","author":"N Charalampakis","year":"2018","unstructured":"Charalampakis N, Economopoulou P, Kotsantis I, Tolia M, Schizas D, Liakakos T, Elimova E, Ajani JA, Psyrri A. Medical management of gastric cancer: a 2017 update. Cancer Med. 2018;7:123\u201333. https:\/\/doi.org\/10.1002\/cam4.1274.","journal-title":"Cancer Med"},{"key":"2467_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.101980","volume":"85","author":"N Joharatnam-Hogan","year":"2020","unstructured":"Joharatnam-Hogan N, Shiu KK, Khan K. Challenges in the treatment of gastric cancer in the older patient. Cancer Treat Rev. 2020;85:101980. https:\/\/doi.org\/10.1016\/j.ctrv.2020.101980.","journal-title":"Cancer Treat Rev"},{"key":"2467_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01591-0","volume":"17","author":"Y Zhang","year":"2024","unstructured":"Zhang Y. LncRNA-encoded peptides in cancer. J Hematol Oncol. 2024;17:66. https:\/\/doi.org\/10.1186\/s13045-024-01591-0.","journal-title":"J Hematol Oncol"},{"key":"2467_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41580-021-00447-6","volume":"23","author":"T Nojima","year":"2022","unstructured":"Nojima T, Proudfoot NJ. Mechanisms of lncRNA biogenesis as revealed by nascent transcriptomics. Nat Rev Mol Cell Biol. 2022;23:389\u2013406. https:\/\/doi.org\/10.1038\/s41580-021-00447-6.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2467_CR9","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1097\/CM9.0000000000000908","volume":"133","author":"X-W Li","year":"2020","unstructured":"Li X-W, Yang W-H, Xu J. Circular RNA in gastric cancer. Chin Med J (Engl). 2020;133:1868\u201377. https:\/\/doi.org\/10.1097\/CM9.0000000000000908.","journal-title":"Chin Med J (Engl)"},{"key":"2467_CR10","doi-asserted-by":"publisher","first-page":"1052942","DOI":"10.3389\/fcell.2023.1052942","volume":"11","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Wang C, Yang Y, Xu R, Li Z. LncRNA and its role in gastric cancer immunotherapy. Front Cell Dev Biol. 2023;11:1052942. https:\/\/doi.org\/10.3389\/fcell.2023.1052942.","journal-title":"Front Cell Dev Biol"},{"key":"2467_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrm.2015.32","volume":"17","author":"L-L Chen","year":"2016","unstructured":"Chen L-L. The biogenesis and emerging roles of circular RNAs. Nat Rev Mol Cell Biol. 2016;17:205\u201311. https:\/\/doi.org\/10.1038\/nrm.2015.32.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2467_CR12","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nsmb.2959","volume":"22","author":"Z Li","year":"2015","unstructured":"Li Z, Huang C, Bao C, Chen L, Lin M, Wang X, Zhong G, Yu B, Hu W, Dai L, Zhu P, Chang Z, Wu Q, Zhao Y, Jia Y, Xu P, Liu H, Shan G. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015;22:256\u201364. https:\/\/doi.org\/10.1038\/nsmb.2959.","journal-title":"Nat Struct Mol Biol"},{"key":"2467_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1552773","volume":"15","author":"W Liu","year":"2025","unstructured":"Liu W, Wang W. LncRNA in gastric cancer drug resistance: deciphering the therapeutic strategies. Front Oncol. 2025;15:1552773. https:\/\/doi.org\/10.3389\/fonc.2025.1552773.","journal-title":"Front Oncol"},{"key":"2467_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s12032-024-02455-w","volume":"41","author":"H Elimam","year":"2024","unstructured":"Elimam H, Abdel Mageed SS, Hatawsh A, Moussa R, Radwan AF, Elfar N, Alhamshry NAA, Abd-Elmawla MA, Mohammed OA, Zaki MB, Doghish AS. Unraveling the influence of LncRNA in gastric cancer pathogenesis: a comprehensive review focus on signaling pathways interplay. Med Oncol Northwood Lond Engl. 2024;41:218. https:\/\/doi.org\/10.1007\/s12032-024-02455-w.","journal-title":"Med Oncol Northwood Lond Engl"},{"key":"2467_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12943-019-0969-3","volume":"18","author":"X Huang","year":"2019","unstructured":"Huang X, Li Z, Zhang Q, Wang W, Li B, Wang L, Xu Z, Zeng A, Zhang X, Zhang X, He Z, Li Q, Sun G, Wang S, Li Q, Wang L, Zhang L, Xu H, Xu Z. Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression. Mol Cancer. 2019;18:71. https:\/\/doi.org\/10.1186\/s12943-019-0969-3.","journal-title":"Mol Cancer"},{"key":"2467_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-01896-9","volume":"40","author":"Y Xia","year":"2021","unstructured":"Xia Y, Lv J, Jiang T, Li B, Li Y, He Z, et al. Circfam73a promotes the cancer stem cell-like properties of gastric cancer through the mir-490-3p\/HMGA2 positive feedback loop and HNRNPK-mediated \u03b2-catenin stabilization. J Exp Clin Cancer Res. 2021;40:103. https:\/\/doi.org\/10.1186\/s13046-021-01896-9.","journal-title":"J Exp Clin Cancer Res"},{"key":"2467_CR17","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1016\/j.ijbiomac.2017.10.154","volume":"107","author":"C Cheng","year":"2018","unstructured":"Cheng C, Qin Y, Zhi Q, Wang J, Qin C. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K\/Akt and Wnt\/\u03b2-catenin signaling pathways by up-regulating miR-34a. Int J Biol Macromol. 2018;107:2620\u20139. https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.10.154.","journal-title":"Int J Biol Macromol"},{"key":"2467_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3233\/CBM-201621","volume":"30","author":"L-J Pei","year":"2021","unstructured":"Pei L-J, Sun P-J, Ma K, Guo Y-Y, Wang L-Y, Liu F-D. LncRNA-SNHG7 interferes with miR-34a to de-sensitize gastric cancer cells to cisplatin. Cancer Biomark. 2021;30:127\u201337. https:\/\/doi.org\/10.3233\/CBM-201621.","journal-title":"Cancer Biomark"},{"key":"2467_CR19","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M, Loewer A, Ziebold U, Landthaler M, Kocks C. Le noble, N. Rajewsky, circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495:333\u20138. https:\/\/doi.org\/10.1038\/nature11928.","journal-title":"Nature"},{"key":"2467_CR20","doi-asserted-by":"publisher","first-page":"e30733","DOI":"10.1371\/journal.pone.0030733","volume":"7","author":"J Salzman","year":"2012","unstructured":"Salzman J, Gawad C, Wang PL, Lacayo N, Brown PO. Circular rnas are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS ONE. 2012;7:e30733. https:\/\/doi.org\/10.1371\/journal.pone.0030733.","journal-title":"PLoS ONE"},{"key":"2467_CR21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1261\/rna.035667.112","volume":"19","author":"WR Jeck","year":"2013","unstructured":"Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, Marzluff WF, Sharpless NE. Circular RNAs are abundant, conserved, and associated with ALU repeats, RNA N. Y N. 2013;19:141\u201357. https:\/\/doi.org\/10.1261\/rna.035667.112.","journal-title":"Y N"},{"key":"2467_CR22","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.cell.2015.02.014","volume":"160","author":"SJ Conn","year":"2015","unstructured":"Conn SJ, Pillman KA, Toubia J, Conn VM, Salmanidis M, Phillips CA, Roslan S, Schreiber AW, Gregory PA, Goodall GJ. The RNA binding protein quaking regulates formation of circrnas. Cell. 2015;160:1125\u201334. https:\/\/doi.org\/10.1016\/j.cell.2015.02.014.","journal-title":"Cell"},{"key":"2467_CR23","doi-asserted-by":"publisher","first-page":"14741","DOI":"10.1038\/ncomms14741","volume":"8","author":"L Errichelli","year":"2017","unstructured":"Errichelli L, Dini Modigliani S, Laneve P, Colantoni A, Legnini I, Capauto D, Rosa A, De Santis R, Scarf\u00f2 R, Peruzzi G, Lu L, Caffarelli E, Shneider NA, Morlando M, Bozzoni I. FUS affects circular RNA expression in murine embryonic stem cell-derived motor neurons. Nat Commun. 2017;8:14741. https:\/\/doi.org\/10.1038\/ncomms14741.","journal-title":"Nat Commun"},{"key":"2467_CR24","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1261\/rna.043687.113","volume":"20","author":"P Gla\u017ear","year":"2014","unstructured":"Gla\u017ear P, Papavasileiou P, Rajewsky N. CircBase: a database for circular rnas, RNA N. Y N. 2014;20:1666\u201370. https:\/\/doi.org\/10.1261\/rna.043687.113.","journal-title":"Y N"},{"key":"2467_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fcell.2018.00020","volume":"6","author":"TB Hansen","year":"2018","unstructured":"Hansen TB. Improved circrna identification by combining prediction algorithms. Front Cell Dev Biol. 2018;6:20. https:\/\/doi.org\/10.3389\/fcell.2018.00020.","journal-title":"Front Cell Dev Biol"},{"key":"2467_CR26","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/bib\/bbx014","volume":"19","author":"Y Gao","year":"2018","unstructured":"Gao Y, Zhang J, Zhao F. Circular RNA identification based on multiple seed matching. Brief Bioinform. 2018;19:803\u201310. https:\/\/doi.org\/10.1093\/bib\/bbx014.","journal-title":"Brief Bioinform"},{"key":"2467_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01270-x","volume":"19","author":"L Peng","year":"2020","unstructured":"Peng L, Sang H, Wei S, Li Y, Jin D, Zhu X, et al. circCUL2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via miR-142-3p\/ROCK2. Mol Cancer. 2020;19:156. https:\/\/doi.org\/10.1186\/s12943-020-01270-x.","journal-title":"Mol Cancer"},{"key":"2467_CR28","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nrg.2016.114","volume":"17","author":"L Szabo","year":"2016","unstructured":"Szabo L, Salzman J. Detecting circular rnas: bioinformatic and experimental challenges. Nat Rev Genet. 2016;17:679\u201392. https:\/\/doi.org\/10.1038\/nrg.2016.114.","journal-title":"Nat Rev Genet"},{"key":"2467_CR29","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55:611\u201322. https:\/\/doi.org\/10.1373\/clinchem.2008.112797.","journal-title":"Clin Chem"},{"key":"2467_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00109-017-1600-y","volume":"96","author":"T Li","year":"2018","unstructured":"Li T, Shao Y, Fu L, Xie Y, Zhu L, Sun W, Yu R, Xiao B, Guo J. Plasma circular RNA profiling of patients with gastric cancer and their droplet digital RT-PCR detection. J Mol Med Berl Ger. 2018;96:85\u201396. https:\/\/doi.org\/10.1007\/s00109-017-1600-y.","journal-title":"J Mol Med Berl Ger"},{"key":"2467_CR31","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1002\/1878-0261.13182","volume":"16","author":"C Pedraz-Valdunciel","year":"2022","unstructured":"Pedraz-Valdunciel C, Giannoukakos S, Potie N, Gim\u00e9nez-Capit\u00e1n A, Huang C-Y, Hackenberg M, Fernandez-Hilario A, Bracht J, Filipska M, Aldeguer E, Rodr\u00edguez S, Bivona TG, Warren S, Aguado C, Ito M, Aguilar-Hern\u00e1ndez A, Molina-Vila MA, Rosell R. Digital multiplexed analysis of circular RNAs in FFPE and fresh non-small cell lung cancer specimens. Mol Oncol. 2022;16:2367\u201383. https:\/\/doi.org\/10.1002\/1878-0261.13182.","journal-title":"Mol Oncol"},{"key":"2467_CR32","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature14443","volume":"521","author":"CA McHugh","year":"2015","unstructured":"McHugh CA, Chen C-K, Chow A, Surka CF, Tran C, McDonel P, Pandya-Jones A, Blanco M, Burghard C, Moradian A, Sweredoski MJ, Shishkin AA, Su J, Lander ES, Hess S, Plath K, Guttman M. The Xist LncRNA interacts directly with SHARP to silence transcription through HDAC3. Nature. 2015;521:232\u20136. https:\/\/doi.org\/10.1038\/nature14443.","journal-title":"Nature"},{"key":"2467_CR33","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/s41588-018-0252-3","volume":"50","author":"J Kim","year":"2018","unstructured":"Kim J, Piao H-L, Kim B-J, Yao F, Han Z, Wang Y, Xiao Z, Siverly AN, Lawhon SE, Ton BN, Lee H, Zhou Z, Gan B, Nakagawa S, Ellis MJ, Liang H, Hung M-C, You MJ, Sun Y, Ma L. Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet. 2018;50:1705\u201315. https:\/\/doi.org\/10.1038\/s41588-018-0252-3.","journal-title":"Nat Genet"},{"key":"2467_CR34","doi-asserted-by":"publisher","first-page":"giz145","DOI":"10.1093\/gigascience\/giz145","volume":"8","author":"H Zheng","year":"2019","unstructured":"Zheng H, Brennan K, Hernaez M, Gevaert O. Benchmark of long non-coding RNA quantification for RNA sequencing of cancer samples. Gigascience. 2019;8:giz145. https:\/\/doi.org\/10.1093\/gigascience\/giz145.","journal-title":"Gigascience"},{"key":"2467_CR35","doi-asserted-by":"publisher","first-page":"9827","DOI":"10.2147\/OTT.S227541","volume":"12","author":"L Gao","year":"2019","unstructured":"Gao L, Xiong D-D, He R-Q, Yang X, Lai Z-F, Liu L-M, Huang Z-G, Wu H-Y, Yang L-H, Ma J, Li S-H, Lin P, Yang H, Luo D-Z, Dang Y-W, Chen G. MIR22HG as A tumor suppressive LncRNA in HCC: A comprehensive analysis integrating RT-qPCR, mRNA-Seq, and microarrays. OncoTargets Ther. 2019;12:9827\u201348. https:\/\/doi.org\/10.2147\/OTT.S227541.","journal-title":"OncoTargets Ther"},{"key":"2467_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2019.111523","volume":"142","author":"Y Bai","year":"2019","unstructured":"Bai Y, Qu Y, Wu Z, Ren Y, Cheng Z, Lu Y, et al. Absolute quantification and analysis of extracellular vesicle LncRNAs from the peripheral blood of patients with lung cancer based on multi-colour fluorescence chip-based digital PCR. Biosens Bioelectron. 2019;142:111523. https:\/\/doi.org\/10.1016\/j.bios.2019.111523.","journal-title":"Biosens Bioelectron"},{"key":"2467_CR37","doi-asserted-by":"publisher","first-page":"20472","DOI":"10.1038\/s41598-020-77252-2","volume":"10","author":"S Rinaldetti","year":"2020","unstructured":"Rinaldetti S, Worst TS, Rempel E, Kriegmair MC, Hartmann A, Porubsky S, Bolenz C, Erben P. Subtype specific expression and survival prediction of pivotal LncRNAs in muscle invasive bladder cancer. Sci Rep. 2020;10:20472. https:\/\/doi.org\/10.1038\/s41598-020-77252-2.","journal-title":"Sci Rep"},{"key":"2467_CR38","doi-asserted-by":"publisher","first-page":"10484","DOI":"10.1038\/s41598-017-09754-5","volume":"7","author":"JB Permuth","year":"2017","unstructured":"Permuth JB, Chen D-T, Yoder SJ, Li J, Smith AT, Choi JW, et al. Linc-ing circulating long non-coding RNAs to the diagnosis and malignant prediction of intraductal papillary mucinous neoplasms of the pancreas. Sci Rep. 2017;7:10484. https:\/\/doi.org\/10.1038\/s41598-017-09754-5.","journal-title":"Sci Rep"},{"key":"2467_CR39","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ccell.2019.01.019","volume":"35","author":"R Esposito","year":"2019","unstructured":"Esposito R, Bosch N, Lanz\u00f3s A, Polidori T, Pulido-Quetglas C, Johnson R. Hacking the cancer genome: profiling therapeutically actionable long non-coding RNAs using CRISPR-Cas9 screening. Cancer Cell. 2019;35:545\u201357. https:\/\/doi.org\/10.1016\/j.ccell.2019.01.019.","journal-title":"Cancer Cell"},{"key":"2467_CR40","doi-asserted-by":"publisher","first-page":"7637","DOI":"10.1016\/j.cell.2024.10.021","volume":"187","author":"W-W Liang","year":"2024","unstructured":"Liang W-W, M\u00fcller S, Hart SK, Wessels H-H, M\u00e9ndez-Mancilla A, Sookdeo A, Choi O, Caragine CM, Corman A, Lu L, Kolumba O, Williams B, Sanjana NE. Transcriptome-scale RNA-targeting CRISPR screens reveal essential LncRNAs in human cells. Cell. 2024;187:7637\u2013e765429. https:\/\/doi.org\/10.1016\/j.cell.2024.10.021.","journal-title":"Cell"},{"key":"2467_CR41","doi-asserted-by":"publisher","first-page":"aah7111","DOI":"10.1126\/science.aah7111","volume":"355","author":"SJ Liu","year":"2017","unstructured":"Liu SJ, Horlbeck MA, Cho SW, Birk HS, Malatesta M, He D, Attenello FJ, Villalta JE, Cho MY, Chen Y, Mandegar MA, Olvera MP, Gilbert LA, Conklin BR, Chang HY, Weissman JS, Lim DA. CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells. Science. 2017;355:aah7111. https:\/\/doi.org\/10.1126\/science.aah7111.","journal-title":"Science"},{"key":"2467_CR42","doi-asserted-by":"publisher","first-page":"eaam8526","DOI":"10.1126\/science.aam8526","volume":"357","author":"M Piwecka","year":"2017","unstructured":"Piwecka M, Gla\u017ear P, Hernandez-Miranda LR, Memczak S, Wolf SA, Rybak-Wolf A, et al. Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function. Science. 2017;357:eaam8526. https:\/\/doi.org\/10.1126\/science.aam8526.","journal-title":"Science"},{"key":"2467_CR43","doi-asserted-by":"publisher","first-page":"11215","DOI":"10.1038\/ncomms11215","volume":"7","author":"Q Zheng","year":"2016","unstructured":"Zheng Q, Bao C, Guo W, Li S, Chen J, Chen B, et al. Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs. Nat Commun. 2016;7:11215. https:\/\/doi.org\/10.1038\/ncomms11215.","journal-title":"Nat Commun"},{"key":"2467_CR44","doi-asserted-by":"publisher","first-page":"4475","DOI":"10.1038\/s41467-018-06862-2","volume":"9","author":"M Zhang","year":"2018","unstructured":"Zhang M, Zhao K, Xu X, Yang Y, Yan S, Wei P, Liu H, Xu J, Xiao F, Zhou H, Yang X, Huang N, Liu J, He K, Xie K, Zhang G, Huang S, Zhang N. A peptide encoded by circular form of LINC-PINT suppresses oncogenic transcriptional elongation in glioblastoma. Nat Commun. 2018;9:4475. https:\/\/doi.org\/10.1038\/s41467-018-06862-2.","journal-title":"Nat Commun"},{"key":"2467_CR45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.molcel.2017.02.017","volume":"66","author":"I Legnini","year":"2017","unstructured":"Legnini I, Di Timoteo G, Rossi F, Morlando M, Briganti F, Sthandier O, Fatica A, Santini T, Andronache A, Wade M, Laneve P, Rajewsky N, Bozzoni I. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Mol Cell. 2017;66:22\u2013e379. https:\/\/doi.org\/10.1016\/j.molcel.2017.02.017.","journal-title":"Mol Cell"},{"key":"2467_CR46","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12943-020-01179-5","volume":"19","author":"Z Pan","year":"2020","unstructured":"Pan Z, Cai J, Lin J, Zhou H, Peng J, Liang J, Xia L, Yin Q, Zou B, Zheng J, Qiao L, Zhang L. A novel protein encoded by circFNDC3B inhibits tumor progression and EMT through regulating snail in colon cancer. Mol Cancer. 2020;19:71. https:\/\/doi.org\/10.1186\/s12943-020-01179-5.","journal-title":"Mol Cancer"},{"key":"2467_CR47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12943-020-1135-7","volume":"19","author":"M Lei","year":"2020","unstructured":"Lei M, Zheng G, Ning Q, Zheng J, Dong D. Translation and functional roles of circular RNAs in human cancer. Mol Cancer. 2020;19:30. https:\/\/doi.org\/10.1186\/s12943-020-1135-7.","journal-title":"Mol Cancer"},{"key":"2467_CR48","doi-asserted-by":"publisher","first-page":"e1657","DOI":"10.1002\/wrna.1657","volume":"12","author":"JB Trotman","year":"2021","unstructured":"Trotman JB, Braceros KCA, Cherney RE, Murvin MM, Calabrese JM. The control of polycomb repressive complexes by long noncoding RNAs. Wiley Interdiscip Rev RNA. 2021;12:e1657. https:\/\/doi.org\/10.1002\/wrna.1657.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"2467_CR49","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.molcel.2019.05.028","volume":"75","author":"MD Schertzer","year":"2019","unstructured":"Schertzer MD, Braceros KCA, Starmer J, Cherney RE, Lee DM, Salazar G, Justice M, Bischoff SR, Cowley DO, Ariel P, Zylka MJ, Dowen JM, Magnuson T, Calabrese JM. lncRNA-Induced spread of polycomb controlled by genome architecture, RNA abundance, and CpG Island DNA. Mol Cell. 2019;75:523\u2013e53710. https:\/\/doi.org\/10.1016\/j.molcel.2019.05.028.","journal-title":"Mol Cell"},{"key":"2467_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112803","volume":"42","author":"AK Braceros","year":"2023","unstructured":"Braceros AK, Schertzer MD, Omer A, Trotman JB, Davis ES, Dowen JM, et al. Proximity-dependent recruitment of polycomb repressive complexes by the LncRNA Airn. Cell Rep. 2023;42:112803. https:\/\/doi.org\/10.1016\/j.celrep.2023.112803.","journal-title":"Cell Rep"},{"key":"2467_CR51","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1016\/j.ymthe.2018.09.002","volume":"26","author":"M Ma","year":"2018","unstructured":"Ma M, Zhang Y, Weng M, Hu Y, Xuan Y, Hu Y, et al. LncRNA GCAWKR promotes gastric cancer development by scaffolding the chromatin modification factors WDR5 and KAT2A. Mol Ther. 2018;26:2658\u201368. https:\/\/doi.org\/10.1016\/j.ymthe.2018.09.002.","journal-title":"Mol Ther"},{"key":"2467_CR52","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s13046-023-02837-4","volume":"42","author":"Y Chen","year":"2023","unstructured":"Chen Y, Lu Y, Yang L, Ma W, Dong Y, Zhou S, Liu N, Gan W, Li D. LncRNA like NMRK2 mRNA functions as a key molecular scaffold to enhance mitochondrial respiration of NONO-TFE3 rearranged renal cell carcinoma in an NAD\u2009+\u2009kinase-independent manner. J Exp Clin Cancer Res CR. 2023;42:252. https:\/\/doi.org\/10.1186\/s13046-023-02837-4.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"2467_CR53","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s13046-022-02543-7","volume":"41","author":"D He","year":"2022","unstructured":"He D, Xin T, Pang B, Sun J, Liu ZH, Qin Z, Ji XS, Yang F, Wei YB, Wang ZX, Gao JJ, Pang Q, Liu Q. A novel LncRNA MDHDH suppresses glioblastoma multiforme by acting as a scaffold for MDH2 and PSMA1 to regulate NAD\u2009+\u2009metabolism and autophagy. J Exp Clin Cancer Res CR. 2022;41:349. https:\/\/doi.org\/10.1186\/s13046-022-02543-7.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"2467_CR54","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nsmb.3005","volume":"22","author":"I Gonzalez","year":"2015","unstructured":"Gonzalez I, Munita R, Agirre E, Dittmer TA, Gysling K, Misteli T, et al. A lncrna regulates alternative splicing via establishment of a splicing-specific chromatin signature. Nat Struct Mol Biol. 2015;22:370\u20136. https:\/\/doi.org\/10.1038\/nsmb.3005.","journal-title":"Nat Struct Mol Biol"},{"key":"2467_CR55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.toxlet.2025.01.001","volume":"404","author":"Y Gao","year":"2025","unstructured":"Gao Y, Wang S, He Y, Ma Y, Wang S. Transcriptional profiling of exosomes derived from serum of patients with rare Earth pneumoconiosis by RNA-sequencing and PI3K\/Akt pathway is activated in lung of mice exposed to rare Earth Nd2O3. Toxicol Lett. 2025;404:9\u201319. https:\/\/doi.org\/10.1016\/j.toxlet.2025.01.001.","journal-title":"Toxicol Lett"},{"key":"2467_CR56","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1023\/a:1012259625746","volume":"12","author":"MJ Piccart","year":"2001","unstructured":"Piccart MJ, Lamb H, Vermorken JB. Current and future potential roles of the platinum drugs in the treatment of ovarian cancer. Ann Oncol Off J Eur Soc Med Oncol. 2001;12:1195\u2013203. https:\/\/doi.org\/10.1023\/a:1012259625746.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"2467_CR57","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1200\/JCO.21.01757","volume":"39","author":"Y Shimanuki","year":"2021","unstructured":"Shimanuki Y, Shimomura A, Yoshimura K, Terakado H, Shimizu C. Are platinum drugs ineffective for triple-negative breast cancer with residual invasive disease after neoadjuvant chemotherapy?? J Clin Oncol. 2021;39:3521\u20132. https:\/\/doi.org\/10.1200\/JCO.21.01757.","journal-title":"J Clin Oncol"},{"key":"2467_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911261","volume":"23","author":"B Buyana","year":"2022","unstructured":"Buyana B, Naki T, Alven S, Aderibigbe BA. Nanoparticles loaded with platinum drugs for colorectal cancer therapy. Int J Mol Sci. 2022;23:11261. https:\/\/doi.org\/10.3390\/ijms231911261.","journal-title":"Int J Mol Sci"},{"key":"2467_CR59","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1158\/1078-0432.CCR-24-3528","volume":"31","author":"SH Lim","year":"2025","unstructured":"Lim SH, An M, Lee H, Heo YJ, Min B-H, Mehta A, et al. Determinants of response to sequential pembrolizumab with trastuzumab plus platinum\/5-FU in HER2-positive gastric cancer: a phase II chemoimmunotherapy trial. Clin Cancer Res. 2025;31:1476\u201390. https:\/\/doi.org\/10.1158\/1078-0432.CCR-24-3528.","journal-title":"Clin Cancer Res"},{"key":"2467_CR60","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1093\/annonc\/mdr291","volume":"23","author":"M Pera","year":"2012","unstructured":"Pera M, Gallego R, Montagut C, Mart\u00edn-Richard M, Iglesias M, Conill C, et al. Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancer. Ann Oncol. 2012;23:664\u201370. https:\/\/doi.org\/10.1093\/annonc\/mdr291.","journal-title":"Ann Oncol"},{"key":"2467_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2025.101211","volume":"79","author":"Y-Y Yan","year":"2025","unstructured":"Yan Y-Y, Deng Z-F, Wu X-T, Lu Y, Zhu Z-Y, Wen Q, et al. Low miR-224-5p in exosomes confers colorectal cancer 5-fu resistance by upregulating S100A4. Drug Resist Updat. 2025;79:101211. https:\/\/doi.org\/10.1016\/j.drup.2025.101211.","journal-title":"Drug Resist Updat"},{"key":"2467_CR62","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1093\/annonc\/mdw176","volume":"27","author":"G Folprecht","year":"2016","unstructured":"Folprecht G, Pericay C, Saunders MP, Thomas A, Lopez Lopez R, Roh JK, et al. Oxaliplatin and 5-FU\/folinic acid (modified FOLFOX6) with or without Aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study. Ann Oncol. 2016;27:1273\u20139. https:\/\/doi.org\/10.1093\/annonc\/mdw176.","journal-title":"Ann Oncol"},{"key":"2467_CR63","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa2004413","volume":"382","author":"K Shitara","year":"2020","unstructured":"Shitara K, Bang Y-J, Iwasa S, Sugimoto N, Ryu M-H, Sakai D, et al. Trastuzumab deruxtecan in previously treated HER2-positive gastric cancer. N Engl J Med. 2020;382:2419\u201330. https:\/\/doi.org\/10.1056\/NEJMoa2004413.","journal-title":"N Engl J Med"},{"key":"2467_CR64","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1038\/s41591-024-02992-x","volume":"30","author":"K Shitara","year":"2024","unstructured":"Shitara K, Bang Y-J, Iwasa S, Sugimoto N, Ryu M-H, Sakai D, et al. Trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory biomarker analysis of the randomized, phase 2 DESTINY-Gastric01 trial. Nat Med. 2024;30:1933\u201342. https:\/\/doi.org\/10.1038\/s41591-024-02992-x.","journal-title":"Nat Med"},{"key":"2467_CR65","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.medj.2024.06.004","volume":"5","author":"N Li","year":"2024","unstructured":"Li N, Qiu M, Zhang Y, Yang M, Lu L, Li W, Ma Y, Hou X, Sun G, Cai M, Wang J, Lu J, Zhong D, Huo Z, Zhang J, Yin X, Deng J, Liu Z, Pan H, Chen Y, Yang F, Yu H, Li J, Wang Q, Zhu J, Li J. A randomized phase 2 study of HLX22 plus trastuzumab biosimilar HLX02 and XELOX as first-line therapy for HER2-positive advanced gastric cancer. Med N Y N. 2024;5:1255\u2013e12652. https:\/\/doi.org\/10.1016\/j.medj.2024.06.004.","journal-title":"Med N Y N"},{"key":"2467_CR66","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1023\/a:1008334913109","volume":"11","author":"I Popov","year":"2000","unstructured":"Popov I, Jeli\u0107 S, Radulovi\u0107 S, Radosavljevi\u0107 D, Nikoli\u0107-Tomasevi\u0107 Z. Eight-hour infusion versus bolus injection of doxorubicin in the EAP regimen in patients with advanced gastric cancer: a prospective randomised trial. Ann Oncol Off J Eur Soc Med Oncol. 2000;11:343\u20138. https:\/\/doi.org\/10.1023\/a:1008334913109.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"2467_CR67","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1093\/annonc\/mdf302","volume":"13","author":"HM Chang","year":"2002","unstructured":"Chang HM, Jung KH, Kim T-Y, Kim WS, Yang H-K, Lee KU, et al. A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer. Ann Oncol. 2002;13:1779\u201385. https:\/\/doi.org\/10.1093\/annonc\/mdf302.","journal-title":"Ann Oncol"},{"key":"2467_CR68","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1200\/JCO.1986.4.9.1348","volume":"4","author":"JA Levi","year":"1986","unstructured":"Levi JA, Fox RM, Tattersall MH, Woods RL, Thomson D, Gill G. Analysis of a prospectively randomized comparison of doxorubicin versus 5-fluorouracil, doxorubicin, and BCNU in advanced gastric cancer: implications for future studies. J Clin Oncol. 1986;4:1348\u201355. https:\/\/doi.org\/10.1200\/JCO.1986.4.9.1348.","journal-title":"J Clin Oncol"},{"key":"2467_CR69","doi-asserted-by":"publisher","first-page":"5281846","DOI":"10.1155\/2022\/5281846","volume":"2022","author":"D Peng","year":"2022","unstructured":"Peng D, Feng L, Li H. Identification of novel circRNA-Based CeRNA network involved in the pathogenesis of gastric cancer. Int J Genomics. 2022;2022:5281846. https:\/\/doi.org\/10.1155\/2022\/5281846.","journal-title":"Int J Genomics"},{"key":"2467_CR70","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41419-022-04720-0","volume":"13","author":"S Qiu","year":"2022","unstructured":"Qiu S, Li B, Xia Y, Xuan Z, Li Z, Xie L, Gu C, Lv J, Lu C, Jiang T, Fang L, Xu P, Yang J, Li Y, Chen Z, Zhang L, Wang L, Zhang D, Xu H, Wang W, Xu Z. CircTHBS1 drives gastric cancer progression by increasing INHBA mRNA expression and stability in a ceRNA- and RBP-dependent manner. Cell Death Dis. 2022;13:266. https:\/\/doi.org\/10.1038\/s41419-022-04720-0.","journal-title":"Cell Death Dis"},{"key":"2467_CR71","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/s12951-024-02760-6","volume":"22","author":"Y Fei","year":"2024","unstructured":"Fei Y, Cao D, Li Y, Wang Z, Dong R, Zhu M, Gao P, Wang X, Cai J, Zuo X. Circ_0008315 promotes tumorigenesis and cisplatin resistance and acts as a nanotherapeutic target in gastric cancer. J Nanobiotechnol. 2024;22:519. https:\/\/doi.org\/10.1186\/s12951-024-02760-6.","journal-title":"J Nanobiotechnol"},{"key":"2467_CR72","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12935-019-0737-x","volume":"19","author":"M Xue","year":"2019","unstructured":"Xue M, Li G, Fang X, Wang L, Jin Y, Zhou Q. Hsa_circ_0081143 promotes cisplatin resistance in gastric cancer by targeting miR-646\/CDK6 pathway. Cancer Cell Int. 2019;19:25. https:\/\/doi.org\/10.1186\/s12935-019-0737-x.","journal-title":"Cancer Cell Int"},{"key":"2467_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05506-0","volume":"14","author":"M Luo","year":"2023","unstructured":"Luo M, Deng X, Chen Z, Hu Y. Circular RNA. circPOFUT1 enhances malignant phenotypes and autophagy-associated chemoresistance via sequestrating miR-488-3p to activate the PLAG1-ATG12 axis in gastric cancer. Cell Death Dis. 2023;14:10. https:\/\/doi.org\/10.1038\/s41419-022-05506-0.","journal-title":"Cell Death Dis"},{"key":"2467_CR74","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18070","volume":"28","author":"B Qu","year":"2024","unstructured":"Qu B, Liu J, Peng Z, Xiao Z, Li S, Wu J, et al. Macrophages enhance cisplatin resistance in gastric cancer through the transfer of circTEX2. J Cell Mol Med. 2024;28:e18070. https:\/\/doi.org\/10.1111\/jcmm.18070.","journal-title":"J Cell Mol Med"},{"key":"2467_CR75","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3748\/wjg.v27.i6.487","volume":"27","author":"P Deng","year":"2021","unstructured":"Deng P, Sun M, Zhao W-Y, Hou B, Li K, Zhang T, Gu F. Circular RNA circvapa promotes chemotherapy drug resistance in gastric cancer progression by regulating miR-125b-5p\/STAT3 axis. World J Gastroenterol. 2021;27:487\u2013500. https:\/\/doi.org\/10.3748\/wjg.v27.i6.487.","journal-title":"World J Gastroenterol"},{"key":"2467_CR76","doi-asserted-by":"publisher","first-page":"389","DOI":"10.5009\/gnl210195","volume":"17","author":"Q Liang","year":"2023","unstructured":"Liang Q, Chu F, Zhang L, Jiang Y, Li L, Wu H. Circ-LDLRAD3 knockdown reduces cisplatin chemoresistance and inhibits the development of gastric cancer with cisplatin resistance through miR-588 enrichment-mediated SOX5 inhibition. Gut Liver. 2023;17:389\u2013403. https:\/\/doi.org\/10.5009\/gnl210195.","journal-title":"Gut Liver"},{"key":"2467_CR77","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.29641","author":"X-X Huang","year":"2020","unstructured":"Huang X-X, Zhang Q, Hu H, Jin Y, Zeng A-L, Xia Y-B, Xu L. A novel circular RNA circFN1 enhances cisplatin resistance in gastric cancer via sponging miR-182-5p. J Cell Biochem. 2020. https:\/\/doi.org\/10.1002\/jcb.29641.","journal-title":"J Cell Biochem"},{"key":"2467_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.767590","volume":"12","author":"R Zhang","year":"2021","unstructured":"Zhang R, Zhao H, Yuan H, Wu J, Liu H, Sun S, et al. Circarvcf contributes to cisplatin resistance in gastric cancer by altering miR-1205 and FGFR1. Front Genet. 2021;12:767590. https:\/\/doi.org\/10.3389\/fgene.2021.767590.","journal-title":"Front Genet"},{"key":"2467_CR79","doi-asserted-by":"publisher","first-page":"5103272","DOI":"10.1155\/2020\/5103272","volume":"2020","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Yu X, Zhou B, Zhang J, Chang J. Circular RNA circ_0026359 enhances cisplatin resistance in gastric cancer via targeting miR-1200\/POLD4 pathway. BioMed Res Int. 2020;2020:5103272. https:\/\/doi.org\/10.1155\/2020\/5103272.","journal-title":"BioMed Res Int"},{"key":"2467_CR80","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12935-020-01358-w","volume":"20","author":"Y Liu","year":"2020","unstructured":"Liu Y, Xu J, Jiang M, Ni L, Ling Y. Circrna DONSON contributes to cisplatin resistance in gastric cancer cells by regulating miR-802\/BMI1 axis. Cancer Cell Int. 2020;20:261. https:\/\/doi.org\/10.1186\/s12935-020-01358-w.","journal-title":"Cancer Cell Int"},{"key":"2467_CR81","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23831","volume":"38","author":"J Ma","year":"2024","unstructured":"Ma J, Zhang S, Gong Y, Wang C. Helicobacter pylori induce circ_0046854 to regulate microRNA-511-3p\/CSF1 axis and enhance the resistance of gastric cancer to cisplatin. J Biochem Mol Toxicol. 2024;38:e23831. https:\/\/doi.org\/10.1002\/jbt.23831.","journal-title":"J Biochem Mol Toxicol"},{"key":"2467_CR82","doi-asserted-by":"publisher","first-page":"11445","DOI":"10.2147\/OTT.S279563","volume":"13","author":"X Yang","year":"2020","unstructured":"Yang X, Zhang Q, Guan B. Circ_0110805 knockdown enhances cisplatin sensitivity and inhibits gastric cancer progression by miR-299-3p\/ENDOPDI axis. OncoTargets Ther. 2020;13:11445\u201357. https:\/\/doi.org\/10.2147\/OTT.S279563.","journal-title":"OncoTargets Ther"},{"key":"2467_CR83","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/1440-1681.13692","volume":"49","author":"B Xu","year":"2022","unstructured":"Xu B, Guo J, Chen M. Circ_0017274 acts on miR-637\/CDX2 axis to facilitate cisplatin resistance in gastric cancer. Clin Exp Pharmacol Physiol. 2022;49:1105\u201315. https:\/\/doi.org\/10.1111\/1440-1681.13692.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2467_CR84","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1097\/CAD.0000000000001386","volume":"33","author":"G Yang","year":"2022","unstructured":"Yang G, Tan J, Guo J, Wu Z, Zhan Q. Exosome-mediated transfer of circ_0063526 enhances cisplatin resistance in gastric cancer cells via regulating miR-449a\/SHMT2 axis. Anticancer Drugs. 2022;33:1047\u201357. https:\/\/doi.org\/10.1097\/CAD.0000000000001386.","journal-title":"Anticancer Drugs"},{"key":"2467_CR85","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1089\/cbr.2020.3578","volume":"36","author":"W Yao","year":"2021","unstructured":"Yao W, Guo P, Mu Q, Wang Y. Exosome-Derived Circ-PVT1 contributes to cisplatin resistance by regulating autophagy, invasion, and apoptosis via miR-30a-5p\/YAP1 axis in gastric cancer cells, cancer biother. Radiopharm. 2021;36:347\u201359. https:\/\/doi.org\/10.1089\/cbr.2020.3578.","journal-title":"Radiopharm"},{"key":"2467_CR86","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20193045","volume":"39","author":"Y-Y Liu","year":"2019","unstructured":"Liu Y-Y, Zhang L-Y, Du W-Z. Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through the regulation of ZEB1 expression by sponging miR-124-3p. Biosci Rep. 2019;39:BSR20193045. https:\/\/doi.org\/10.1042\/BSR20193045.","journal-title":"Biosci Rep"},{"key":"2467_CR87","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1080\/1120009X.2022.2151702","volume":"35","author":"Y Wang","year":"2023","unstructured":"Wang Y, Tang S, Li L, Sun C, Liu Y, Zhao Y. Depletion of circPDSS1 inhibits ITGA11 production to confer cisplatin sensitivity through miR-515-5p in gastric cancer. J Chemother. 2023;35:514\u201326. https:\/\/doi.org\/10.1080\/1120009X.2022.2151702.","journal-title":"J Chemother"},{"key":"2467_CR88","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1097\/CAD.0000000000001087","volume":"32","author":"Y Sun","year":"2021","unstructured":"Sun Y, Ma J, Lin J, Sun D, Song P, Shi L, et al. Circular RNA. circ_ASAP2 regulates drug sensitivity and functional behaviors of cisplatin-resistant gastric cancer cells by the miR-330-3p\/NT5E axis. Anti-Cancer Drugs. 2021;32:950\u201361. https:\/\/doi.org\/10.1097\/CAD.0000000000001087.","journal-title":"Anti-Cancer Drugs"},{"key":"2467_CR89","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1002\/jcp.31093","volume":"238","author":"Z Shang","year":"2023","unstructured":"Shang Z, Luo Z, Wang Y, Liu Q, Xin Y, Zhang M, et al. CircHIPK3 contributes to cisplatin resistance in gastric cancer by blocking autophagy-dependent ferroptosis. J Cell Physiol. 2023;238:2407\u201324. https:\/\/doi.org\/10.1002\/jcp.31093.","journal-title":"J Cell Physiol"},{"key":"2467_CR90","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.bbrc.2020.03.156","volume":"526","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Miao Y, Fu Q, Hu H, Chen H, Zeng A, et al. CircRNACCDC66 regulates cisplatin resistance in gastric cancer via the miR-618\/BCL2 axis. Biochem Biophys Res Commun. 2020;526:713\u201320. https:\/\/doi.org\/10.1016\/j.bbrc.2020.03.156.","journal-title":"Biochem Biophys Res Commun"},{"key":"2467_CR91","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s13577-022-00790-6","volume":"36","author":"Y Chen","year":"2023","unstructured":"Chen Y, Liu H, Zou J, Cao G, Li Y, Xing C, Wu J. Exosomal circ_0091741 promotes gastric cancer cell autophagy and chemoresistance via the miR-330-3p\/TRIM14\/Dvl2\/Wnt\/\u03b2-catenin axis. Hum Cell. 2023;36:258\u201375. https:\/\/doi.org\/10.1007\/s13577-022-00790-6.","journal-title":"Hum Cell"},{"key":"2467_CR92","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1080\/15384101.2022.2146839","volume":"22","author":"D Yu","year":"2023","unstructured":"Yu D, Chang Z, Liu X, Chen P, Zhang H, Qin Y. Macrophage-derived exosomes regulate gastric cancer cell oxaliplatin resistance by wrapping circ 0008253. Cell Cycle Georget Tex. 2023;22:705\u201317. https:\/\/doi.org\/10.1080\/15384101.2022.2146839.","journal-title":"Cell Cycle Georget Tex"},{"key":"2467_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155596","volume":"263","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Zhang Q, Xu Q, Liao B, Qiu X. Circ_0006089 facilitates gastric cancer progression and oxaliplatin resistance via miR-217\/NRP1. Pathol Res Pract. 2024;263:155596. https:\/\/doi.org\/10.1016\/j.prp.2024.155596.","journal-title":"Pathol Res Pract"},{"key":"2467_CR94","doi-asserted-by":"publisher","first-page":"647","DOI":"10.14670\/HH-18-506","volume":"38","author":"C Xiang","year":"2023","unstructured":"Xiang C, Li R, Qiu H, Zuo E, Zhang Y, Shan L, Cheng X, Circular RNA. circLRCH3 promotes oxaliplatin resistance in gastric cancer through the modulation of the miR-383-5p\/FGF7 axis. Histol Histopathol. 2023;38:647\u201358. https:\/\/doi.org\/10.14670\/HH-18-506.","journal-title":"Histol Histopathol"},{"key":"2467_CR95","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.2147\/OTT.S281238","volume":"14","author":"H Gao","year":"2021","unstructured":"Gao H, Xu J, Qiao F, Xue L. Depletion of hsa_circ_0000144 suppresses oxaliplatin resistance of gastric cancer cells by regulating miR-502-5p\/ADAM9 axis. OncoTargets Ther. 2021;14:2773\u201387. https:\/\/doi.org\/10.2147\/OTT.S281238.","journal-title":"OncoTargets Ther"},{"key":"2467_CR96","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10529-020-03036-3","volume":"43","author":"Y Zhong","year":"2021","unstructured":"Zhong Y, Wang D, Ding Y, Tian G, Jiang B. Circular RNA circ_0032821 contributes to oxaliplatin (OXA) resistance of gastric cancer cells by regulating SOX9 via miR-515-5p. Biotechnol Lett. 2021;43:339\u201351. https:\/\/doi.org\/10.1007\/s10529-020-03036-3.","journal-title":"Biotechnol Lett"},{"key":"2467_CR97","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.708","volume":"12","author":"L Fang","year":"2022","unstructured":"Fang L, Lv J, Xuan Z, Li B, Li Z, He Z, et al. Circular CPM promotes chemoresistance of gastric cancer via activating PRKAA2-mediated autophagy. Clin Transl Med. 2022;12:e708. https:\/\/doi.org\/10.1002\/ctm2.708.","journal-title":"Clin Transl Med"},{"key":"2467_CR98","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.2147\/CMAR.S246272","volume":"12","author":"G Xu","year":"2020","unstructured":"Xu G, Li M, Wu J, Qin C, Tao Y, He H. Circular RNA circNRIP1 sponges microRNA-138-5p to maintain Hypoxia-induced resistance to 5-Fluorouracil through HIF-1\u03b1-dependent glucose metabolism in gastric carcinoma. Cancer Manag Res. 2020;12:2789\u2013802. https:\/\/doi.org\/10.2147\/CMAR.S246272.","journal-title":"Cancer Manag Res"},{"key":"2467_CR99","doi-asserted-by":"publisher","first-page":"173","DOI":"10.21873\/anticanres.17403","volume":"45","author":"F Zhou","year":"2024","unstructured":"Zhou F, Zhuo J, Xu X, Pan D, Cai C, Huang J, et al. Circular RNA hsa_circ_0004650 enhances 5-fluorouracil resistance in gastric cancer via sponging miR-145-5p. Anticancer Res. 2024;45:173\u201387. https:\/\/doi.org\/10.21873\/anticanres.17403.","journal-title":"Anticancer Res"},{"key":"2467_CR100","doi-asserted-by":"publisher","first-page":"861","DOI":"10.5009\/gnl210354","volume":"16","author":"W Ou","year":"2022","unstructured":"Ou W, Lin L, Chen R, Xu Q, Zhou C. Circ_0081143 contributes to gastric cancer malignant development and doxorubicin resistance by elevating the expression of YES1 by targeting mziR-129-2-3p. Gut Liver. 2022;16:861\u201374. https:\/\/doi.org\/10.5009\/gnl210354.","journal-title":"Gut Liver"},{"key":"2467_CR101","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3349\/ymj.2020.61.9.750","volume":"61","author":"S Wang","year":"2020","unstructured":"Wang S, Ping M, Song B, Guo Y, Li Y, Jia J. Exosomal CircPRRX1 enhances doxorubicin resistance in gastric cancer by regulating MiR-3064-5p\/PTPN14 signaling. Yonsei Med J. 2020;61:750\u201361. https:\/\/doi.org\/10.3349\/ymj.2020.61.9.750.","journal-title":"Yonsei Med J"},{"key":"2467_CR102","doi-asserted-by":"publisher","first-page":"147733","DOI":"10.1016\/j.gene.2023.147733","volume":"887","author":"B Qu","year":"2023","unstructured":"Qu B, Liu J, Peng Z, Xiao Z, Li S, Wu J, Li S, Luo J. CircSOD2 polarizes macrophages towards the M1 phenotype to alleviate cisplatin resistance in gastric cancer cells by targeting the miR-1296\/STAT1 axis. Gene. 2023;887:147733. https:\/\/doi.org\/10.1016\/j.gene.2023.147733.","journal-title":"Gene"},{"key":"2467_CR103","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/CAD.0000000000001391","volume":"34","author":"W Cheng","year":"2023","unstructured":"Cheng W, Luan P, Jin X. CircUBAP2 inhibits cisplatin resistance in gastric cancer via miR-300\/KAT6B axis. Anti-Cancer Drugs. 2023;34:126\u201334. https:\/\/doi.org\/10.1097\/CAD.0000000000001391.","journal-title":"Anti-Cancer Drugs"},{"key":"2467_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-020-01758-w","volume":"39","author":"G Sun","year":"2020","unstructured":"Sun G, Li Z, He Z, Wang W, Wang S, Zhang X, et al. Circular RNA MCTP2 inhibits cisplatin resistance in gastric cancer by miR-99a-5p-mediated induction of MTMR3 expression. J Exp Clin Cancer Res. 2020;39:246. https:\/\/doi.org\/10.1186\/s13046-020-01758-w.","journal-title":"J Exp Clin Cancer Res"},{"key":"2467_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107206","volume":"204","author":"X-Y Chen","year":"2024","unstructured":"Chen X-Y, Yang Y-L, Yu Y, Chen Z-Y, Fan H-N, Zhang J, et al. Circuggt2 downregulation by METTL14-dependent m6A modification suppresses gastric cancer progression and cisplatin resistance through interaction with miR-186-3p\/MAP3K9 axis. Pharmacol Res. 2024;204:107206. https:\/\/doi.org\/10.1016\/j.phrs.2024.107206.","journal-title":"Pharmacol Res"},{"key":"2467_CR106","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s10528-021-10110-6","volume":"60","author":"J Zhang","year":"2022","unstructured":"Zhang J, Zha W, Qian C, Ding A, Mao Z. Circular RNA circ_0001017 sensitizes Cisplatin-resistant gastric cancer cells to chemotherapy by the miR-543\/PHLPP2 axis. Biochem Genet. 2022;60:558\u201375. https:\/\/doi.org\/10.1007\/s10528-021-10110-6.","journal-title":"Biochem Genet"},{"key":"2467_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114315","volume":"443","author":"L Xin","year":"2024","unstructured":"Xin L, Zou Y-H, Liu C-X, Lu H, Fan L-J, Xu H-S, et al. Methionine restriction promotes cisplatin sensitivity of gastric cancer resistant cells by down-regulating circ-CDK13 level. Exp Cell Res. 2024;443:114315. https:\/\/doi.org\/10.1016\/j.yexcr.2024.114315.","journal-title":"Exp Cell Res"},{"key":"2467_CR108","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s42003-024-06213-6","volume":"7","author":"Q-Y Chen","year":"2024","unstructured":"Chen Q-Y, Xu K-X, Huang X-B, Fan D-H, Chen Y-J, Li Y-F, Huang Q, Liu Z-Y, Zheng H-L, Huang Z-N, Lin Z-H, Wang Y-X, Yang J-J, Zhong Q, Huang C-M. Circ-0075305 hinders gastric cancer stem cells by indirectly disrupting TCF4-\u03b2-catenin complex and downregulation of SOX9. Commun Biol. 2024;7:545. https:\/\/doi.org\/10.1038\/s42003-024-06213-6.","journal-title":"Commun Biol"},{"key":"2467_CR109","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23449","volume":"34","author":"X Lv","year":"2020","unstructured":"Lv X, Li P, Wang J, Gao H, Hei Y, Zhang J, et al. hsa_circ_0000520 influences Herceptin resistance in gastric cancer cells through PI3K-Akt signaling pathway. J Clin Lab Anal. 2020;34:e23449. https:\/\/doi.org\/10.1002\/jcla.23449.","journal-title":"J Clin Lab Anal"},{"key":"2467_CR110","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12943-018-0874-1","volume":"17","author":"X-Z Yang","year":"2018","unstructured":"Yang X-Z, Cheng T-T, He Q-J, Lei Z-Y, Chi J, Tang Z, et al. LINC01133 as cerna inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt\/\u03b2-catenin pathway. Mol Cancer. 2018;17:126. https:\/\/doi.org\/10.1186\/s12943-018-0874-1.","journal-title":"Mol Cancer"},{"key":"2467_CR111","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12943-018-0829-6","volume":"17","author":"G Zhang","year":"2018","unstructured":"Zhang G, Li S, Lu J, Ge Y, Wang Q, Ma G, Zhao Q, Wu D, Gong W, Du M, Chu H, Wang M, Zhang A, Zhang Z. LncRNA MT1JP functions as a CeRNA in regulating FBXW7 through competitively binding to miR-92a-3p in gastric cancer. Mol Cancer. 2018;17:87. https:\/\/doi.org\/10.1186\/s12943-018-0829-6.","journal-title":"Mol Cancer"},{"key":"2467_CR112","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/mc.23155","volume":"59","author":"Y Ma","year":"2020","unstructured":"Ma Y, Liu Y, Pu Y-S, Cui M-L, Mao Z-J, Li Z-Z, et al. LncRNA IGFL2-AS1 functions as a CeRNA in regulating ARPP19 through competitive binding to miR-802 in gastric cancer. Mol Carcinog. 2020;59:311\u201322. https:\/\/doi.org\/10.1002\/mc.23155.","journal-title":"Mol Carcinog"},{"key":"2467_CR113","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jare.2021.10.001","volume":"37","author":"H Yang","year":"2022","unstructured":"Yang H, Hu Y, Weng M, Liu X, Wan P, Hu Y, Ma M, Zhang Y, Xia H, Lv K. Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer. J Adv Res. 2022;37:91\u2013106. https:\/\/doi.org\/10.1016\/j.jare.2021.10.001.","journal-title":"J Adv Res"},{"key":"2467_CR114","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.703","volume":"12","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Zhou B, Hu X, Ying S, Zhou Q, Xu W, et al. LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability. Clin Transl Med. 2022;12:e703. https:\/\/doi.org\/10.1002\/ctm2.703.","journal-title":"Clin Transl Med"},{"key":"2467_CR115","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.7150\/jca.43446","volume":"11","author":"Q Dai","year":"2020","unstructured":"Dai Q, Zhang T, Pan J, Li C. LncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K\/AKT pathway. J Cancer. 2020;11:3882\u201392. https:\/\/doi.org\/10.7150\/jca.43446.","journal-title":"J Cancer"},{"key":"2467_CR116","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2147\/CMAR.S277399","volume":"13","author":"H Cheng","year":"2021","unstructured":"Cheng H, Sharen G, Wang Z, Zhou J. LncRNA UCA1 enhances cisplatin resistance by regulating CYP1B1-mediated apoptosis via miR-513a-3p in human gastric cancer. Cancer Manag Res. 2021;13:367\u201377. https:\/\/doi.org\/10.2147\/CMAR.S277399.","journal-title":"Cancer Manag Res"},{"key":"2467_CR117","doi-asserted-by":"publisher","first-page":"11325","DOI":"10.2147\/OTT.S231846","volume":"12","author":"J Wang","year":"2019","unstructured":"Wang J, Lv B, Su Y, Wang X, Bu J, Yao L. Exosome-Mediated transfer of LncRNA HOTTIP promotes cisplatin resistance in gastric cancer cells by regulating HMGA1\/miR-218 axis. OncoTargets Ther. 2019;12:11325\u201338. https:\/\/doi.org\/10.2147\/OTT.S231846.","journal-title":"OncoTargets Ther"},{"key":"2467_CR118","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.biopha.2017.04.111","volume":"92","author":"X Zhang","year":"2017","unstructured":"Zhang X, Bo P, Liu L, Zhang X, Li J. Overexpression of long non-coding RNA GHET1 promotes the development of multidrug resistance in gastric cancer cells. Biomed Pharmacother Biomedecine Pharmacother. 2017;92:580\u20135. https:\/\/doi.org\/10.1016\/j.biopha.2017.04.111.","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"2467_CR119","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202052124","volume":"22","author":"L Xin","year":"2021","unstructured":"Xin L, Zhou L-Q, Liu C, Zeng F, Yuan Y-W, Zhou Q, et al. Transfer of lncRNA CRNDE in TAM-derived exosomes is linked with cisplatin resistance in gastric cancer. EMBO Rep. 2021;22:e52124. https:\/\/doi.org\/10.15252\/embr.202052124.","journal-title":"EMBO Rep"},{"key":"2467_CR120","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12943-020-01299-y","volume":"20","author":"F Zhang","year":"2021","unstructured":"Zhang F, Wang H, Yu J, Yao X, Yang S, Li W, Xu L, Zhao L. LncRNA CRNDE attenuates chemoresistance in gastric cancer via SRSF6-regulated alternative splicing of PICALM. Mol Cancer. 2021;20:6. https:\/\/doi.org\/10.1186\/s12943-020-01299-y.","journal-title":"Mol Cancer"},{"key":"2467_CR121","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.2147\/CMAR.S243796","volume":"12","author":"Q Dai","year":"2020","unstructured":"Dai Q, Zhang T, Li C. LncRNA MALAT1 regulates the cell proliferation and cisplatin resistance in gastric cancer via PI3K\/AKT pathway, cancer Manag. Res. 2020;12:1929\u201339. https:\/\/doi.org\/10.2147\/CMAR.S243796.","journal-title":"Res"},{"key":"2467_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117280","volume":"244","author":"Y-F Zhang","year":"2020","unstructured":"Zhang Y-F, Li C-S, Zhou Y, Lu X-H. Propofol facilitates cisplatin sensitivity via LncRNA MALAT1\/miR-30e\/ATG5 axis through suppressing autophagy in gastric cancer. Life Sci. 2020;244:117280. https:\/\/doi.org\/10.1016\/j.lfs.2020.117280.","journal-title":"Life Sci"},{"key":"2467_CR123","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3892\/ijo.2018.4609","volume":"54","author":"Z Xi","year":"2019","unstructured":"Xi Z, Si J, Nan J. LncRNA MALAT1 potentiates autophagy\u2013associated cisplatin resistance by regulating the microRNA\u201330b\/autophagy\u2013related gene 5 axis in gastric cancer. Int J Oncol. 2019;54:239\u201348. https:\/\/doi.org\/10.3892\/ijo.2018.4609.","journal-title":"Int J Oncol"},{"key":"2467_CR124","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2147\/CMAR.S269679","volume":"13","author":"X Miao","year":"2021","unstructured":"Miao X, Liu Y, Fan Y, Wang G, Zhu H. LncRNA BANCR attenuates the killing capacity of cisplatin on gastric cancer cell through the ERK1\/2 pathway. Cancer Manag Res. 2021;13:287\u201396. https:\/\/doi.org\/10.2147\/CMAR.S269679.","journal-title":"Cancer Manag Res"},{"key":"2467_CR125","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.4149\/neo_2021_210317N356","volume":"68","author":"H Ren","year":"2021","unstructured":"Ren H, Tang L. Hdac3-mediated lncRNA-LOC101928316 contributes to cisplatin resistance in gastric cancer via activating the PI3K-Akt-mTOR pathway. Neoplasma. 2021_;68:1043\u201351. https:\/\/doi.org\/10.4149\/neo_2021_210317N356.","journal-title":"Neoplasma"},{"key":"2467_CR126","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/cac2.12507","volume":"44","author":"C Liu","year":"2024","unstructured":"Liu C, Shen A, Song J, Cheng L, Zhang M, Wang Y, et al. LncRNA-CCAT5-mediated crosstalk between Wnt\/\u03b2-catenin and STAT3 signaling suggests novel therapeutic approaches for metastatic gastric cancer with high Wnt activity. Cancer Commun Lond Engl. 2024;44:76\u2013100. https:\/\/doi.org\/10.1002\/cac2.12507.","journal-title":"Cancer Commun Lond Engl"},{"issue":"10","key":"2467_CR127","doi-asserted-by":"publisher","first-page":"7891","DOI":"10.1007\/s00210-024-03130-7","volume":"397","author":"SS Azadi","year":"2024","unstructured":"Azadi SS, Safaralizadeh R, Amini M, Hosseinpour Feizi MA, Abdolzadeh S, Najafi S, et al. Investigating the effect of LncRNA DLGAP1-AS2 suppression on chemosensitivity of gastric cancer to chemotherapy. Naunyn-Schmiedebergs Arch Pharmacol. 2024;397(10):7891\u2013903. https:\/\/doi.org\/10.1007\/s00210-024-03130-7.","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"2467_CR128","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1038\/s41388-019-0747-0","volume":"38","author":"W He","year":"2019","unstructured":"He W, Liang B, Wang C, Li S, Zhao Y, Huang Q, et al. MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer. Oncogene. 2019;38:4637\u201354. https:\/\/doi.org\/10.1038\/s41388-019-0747-0.","journal-title":"Oncogene"},{"key":"2467_CR129","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.18632\/aging.204165","volume":"14","author":"K Ye","year":"2022","unstructured":"Ye K, Wang Y. Long non-coding RNA ZNF674-AS1 antagonizes oxaliplatin resistance of gastric cancer via regulating EZH2-mediated methylation of CHST7. Aging. 2022;14:5523\u201336. https:\/\/doi.org\/10.18632\/aging.204165.","journal-title":"Aging"},{"key":"2467_CR130","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00715","volume":"11","author":"Y Gao","year":"2020","unstructured":"Gao Y, Xie M, Guo Y, Yang Q, Hu S, Li Z. Long non-coding RNA FGD5-AS1 regulates cancer cell proliferation and chemoresistance in gastric cancer through miR-153-3p\/CITED2 axis. Front Genet. 2020;11:715. https:\/\/doi.org\/10.3389\/fgene.2020.00715.","journal-title":"Front Genet"},{"key":"2467_CR131","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40170-022-00293-w","volume":"10","author":"Y Ding","year":"2022","unstructured":"Ding Y, Gao S, Zheng J, Chen X. Blocking lncRNA-SNHG16 sensitizes gastric cancer cells to 5-Fu through targeting the miR-506-3p-PTBP1-mediated glucose metabolism. Cancer Metab. 2022;10:20. https:\/\/doi.org\/10.1186\/s40170-022-00293-w.","journal-title":"Cancer Metab"},{"key":"2467_CR132","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.749129","volume":"9","author":"Z Gui","year":"2021","unstructured":"Gui Z, Zhao Z, Sun Q, Shao G, Huang J, Zhao W, et al. LncRNA FEZF1-AS1 promotes multi-drug resistance of gastric cancer cells via upregulating ATG5. Front Cell Dev Biol. 2021;9:749129. https:\/\/doi.org\/10.3389\/fcell.2021.749129.","journal-title":"Front Cell Dev Biol"},{"key":"2467_CR133","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2424513","volume":"56","author":"Z Chen","year":"2024","unstructured":"Chen Z, Zhang X, Li Z, Zhang H, Wang Z. LncRNA LINC02323 predicts adverse neoadjuvant chemotherapy outcomes of gastric cancer patients and regulates cell sensitivity to 5-fluorouracil by negatively modulating miR-139-3p. Ann Med. 2024;56:2424513. https:\/\/doi.org\/10.1080\/07853890.2024.2424513.","journal-title":"Ann Med"},{"key":"2467_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101351","volume":"18","author":"L Jiang","year":"2022","unstructured":"Jiang L, Zhang Y, Su P, Ma Z, Ye X, Kang W, et al. Long non-coding RNA HNF1A-AS1 induces 5-FU resistance of gastric cancer through miR-30b-5p\/EIF5A2 pathway. Transl Oncol. 2022;18:101351. https:\/\/doi.org\/10.1016\/j.tranon.2022.101351.","journal-title":"Transl Oncol"},{"key":"2467_CR135","doi-asserted-by":"publisher","first-page":"933","DOI":"10.7150\/ijms.82216","volume":"20","author":"H Lin","year":"2023","unstructured":"Lin H, Ni R, Li D, Zhao M, Li Y, Li K, et al. LncRNA MIR155HG overexpression promotes proliferation, migration, and chemoresistance in gastric cancer cells. Int J Med Sci. 2023;20:933\u201342. https:\/\/doi.org\/10.7150\/ijms.82216.","journal-title":"Int J Med Sci"},{"key":"2467_CR136","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1080\/15548627.2021.1901204","volume":"17","author":"Y Luo","year":"2021","unstructured":"Luo Y, Zheng S, Wu Q, Wu J, Zhou R, Wang C, et al. Long noncoding RNA (lncRNA) EIF3J-DT induces chemoresistance of gastric cancer via autophagy activation. Autophagy. 2021;17:4083\u2013101. https:\/\/doi.org\/10.1080\/15548627.2021.1901204.","journal-title":"Autophagy"},{"key":"2467_CR137","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41419-020-2426-z","volume":"11","author":"H Wu","year":"2020","unstructured":"Wu H, Liu B, Chen Z, Li G, Zhang Z. MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p\/AMPK\/PGC1\u03b1\/CEBPB axis to promote stemness and chemo-resistance of gastric cancer. Cell Death Dis. 2020;11:233. https:\/\/doi.org\/10.1038\/s41419-020-2426-z.","journal-title":"Cell Death Dis"},{"key":"2467_CR138","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41419-019-1585-2","volume":"10","author":"L Zhu","year":"2019","unstructured":"Zhu L, Zhu Y, Han S, Chen M, Song P, Dai D, Xu W, Jiang T, Feng L, Shin VY, Wang X, Jin H. Impaired autophagic degradation of LncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer. Cell Death Dis. 2019;10:383. https:\/\/doi.org\/10.1038\/s41419-019-1585-2.","journal-title":"Cell Death Dis"},{"key":"2467_CR139","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ncrna.2024.07.004","volume":"10","author":"B Wang","year":"2025","unstructured":"Wang B, Liu W, Song B, Li Y, Wang Y, Tan B. Targeting LINC00665\/miR-199b-5p\/SERPINE1 axis to inhibit trastuzumab resistance and tumorigenesis of gastric cancer via PI3K\/AKt pathway, Non-Coding. RNA Res. 2025;10:153\u201362. https:\/\/doi.org\/10.1016\/j.ncrna.2024.07.004.","journal-title":"RNA Res"},{"key":"2467_CR140","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13046-024-03103-x","volume":"43","author":"S Qin","year":"2024","unstructured":"Qin S, Liu Y, Zhang X, Huang P, Xia L, Leng W, Li D. LncRNA FGD5-AS1 is required for gastric cancer proliferation by inhibiting cell senescence and ROS production via stabilizing YBX1. J Exp Clin Cancer Res CR. 2024;43:188. https:\/\/doi.org\/10.1186\/s13046-024-03103-x.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"2467_CR141","doi-asserted-by":"publisher","first-page":"11025","DOI":"10.18632\/aging.103314","volume":"12","author":"N Ren","year":"2020","unstructured":"Ren N, Jiang T, Wang C, Xie S, Xing Y, Piao D, Zhang T, Zhu Y. LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p\/NLRP3 axis. Aging. 2020;12:11025\u201341. https:\/\/doi.org\/10.18632\/aging.103314.","journal-title":"Aging"},{"key":"2467_CR142","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1007\/s00432-019-03015-w","volume":"145","author":"L Xin","year":"2019","unstructured":"Xin L, Zhou Q, Yuan Y-W, Zhou L-Q, Liu L, Li S-H, Liu C. METase\/lncRNA HULC\/FoxM1 reduced cisplatin resistance in gastric cancer by suppressing autophagy. J Cancer Res Clin Oncol. 2019;145:2507\u201317. https:\/\/doi.org\/10.1007\/s00432-019-03015-w.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2467_CR143","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S1470-2045(23)00404-7","volume":"24","author":"K Shiraishi","year":"2023","unstructured":"Shiraishi K, Yamamoto S, Kato K. Combination immunotherapy in chemotherapy in gastric cancer. Lancet Oncol. 2023;24:1054\u20135. https:\/\/doi.org\/10.1016\/S1470-2045(23)00404-7.","journal-title":"Lancet Oncol"},{"key":"2467_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188615","volume":"1876","author":"K Li","year":"2021","unstructured":"Li K, Zhang A, Li X, Zhang H, Zhao L. Advances in clinical immunotherapy for gastric cancer. Biochimica et Biophysica Acta (BBA). 2021;1876:188615. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188615.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"2467_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2021.104469","volume":"372","author":"Z Guo","year":"2022","unstructured":"Guo Z, Zhou C, Zhou L, Wang Z, Zhu X, Mu X. Overexpression of DAPK1-mediated inhibition of IKK\u03b2\/CSN5\/PD-L1 axis enhances natural killer cell killing ability and inhibits tumor immune evasion in gastric cancer. Cell Immunol. 2022;372:104469. https:\/\/doi.org\/10.1016\/j.cellimm.2021.104469.","journal-title":"Cell Immunol"},{"key":"2467_CR146","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12943-023-01883-y","volume":"22","author":"Z Miao","year":"2023","unstructured":"Miao Z, Li J, Wang Y, Shi M, Gu X, Zhang X, Wei F, Tang X, Zheng L, Xing Y. Hsa_circ_0136666 stimulates gastric cancer progression and tumor immune escape by regulating the miR-375\/PRKDC axis and PD-L1 phosphorylation. Mol Cancer. 2023;22:205. https:\/\/doi.org\/10.1186\/s12943-023-01883-y.","journal-title":"Mol Cancer"},{"key":"2467_CR147","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1186\/s12967-024-05498-9","volume":"22","author":"Y Li","year":"2024","unstructured":"Li Y, Wang Z, Gao P, Cao D, Dong R, Zhu M, et al. Circrhbdd1 promotes immune escape via IGF2BP2\/PD-L1 signaling and acts as a nanotherapeutic target in gastric cancer. J Transl Med. 2024;22:704. https:\/\/doi.org\/10.1186\/s12967-024-05498-9.","journal-title":"J Transl Med"},{"key":"2467_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110121","volume":"119","author":"C Wu","year":"2023","unstructured":"Wu C, Cao X, Xu J, Wang L, Huang J, Wen J, et al. Hsa_circ_0073453 modulates IL-8 secretion by GC-MSCs to promote gastric cancer progression by sponging miR-146a-5p. Int Immunopharmacol. 2023;119:110121. https:\/\/doi.org\/10.1016\/j.intimp.2023.110121.","journal-title":"Int Immunopharmacol"},{"key":"2467_CR149","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12943-019-1032-0","volume":"18","author":"C-J Wang","year":"2019","unstructured":"Wang C-J, Zhu C-C, Xu J, Wang M, Zhao W-Y, Liu Q, et al. The LncRNA UCA1 promotes proliferation, migration, immune escape and inhibits apoptosis in gastric cancer by sponging anti-tumor miRNAs. Mol Cancer. 2019;18:115. https:\/\/doi.org\/10.1186\/s12943-019-1032-0.","journal-title":"Mol Cancer"},{"key":"2467_CR150","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.2147\/CMAR.S275352","volume":"13","author":"T Guo","year":"2021","unstructured":"Guo T, Wang W, Ji Y, Zhang M, Xu G, Lin S. LncRNA PROX1-AS1 facilitates gastric cancer progression via miR-877-5p\/PD-L1 axis. Cancer Manag Res. 2021;13:2669\u201380. https:\/\/doi.org\/10.2147\/CMAR.S275352.","journal-title":"Cancer Manag Res"},{"key":"2467_CR151","doi-asserted-by":"publisher","first-page":"8547","DOI":"10.2147\/OTT.S251625","volume":"13","author":"S Dang","year":"2020","unstructured":"Dang S, Malik A, Chen J, Qu J, Yin K, Cui L, Gu M. LncRNA SNHG15 contributes to Immuno-Escape of gastric cancer through targeting miR141\/PD-L1. OncoTargets Ther. 2020;13:8547\u201356. https:\/\/doi.org\/10.2147\/OTT.S251625.","journal-title":"OncoTargets Ther"},{"key":"2467_CR152","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12943-021-01475-8","volume":"20","author":"D-L Chen","year":"2021","unstructured":"Chen D-L, Sheng H, Zhang D-S, Jin Y, Zhao B-T, Chen N, Song K, Xu R-H. The circular RNA circDLG1 promotes gastric cancer progression and anti-PD-1 resistance through the regulation of CXCL12 by sponging miR-141-3p. Mol Cancer. 2021;20:166. https:\/\/doi.org\/10.1186\/s12943-021-01475-8.","journal-title":"Mol Cancer"},{"key":"2467_CR153","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1186\/s12951-024-02826-5","volume":"22","author":"B Wang","year":"2024","unstructured":"Wang B, Liu W, Zhang M, Li Y, Tang H, Wang Y, et al. Circ_0001947 encapsulated by small extracellular vesicles promotes gastric cancer progression and anti-PD-1 resistance by modulating CD8\u2009+\u2009t cell exhaustion. J Nanobiotechnol. 2024;22:563. https:\/\/doi.org\/10.1186\/s12951-024-02826-5.","journal-title":"J Nanobiotechnol"},{"key":"2467_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110887","volume":"124","author":"J Zang","year":"2023","unstructured":"Zang J, Xiao L, Shi X, Liu S, Wang Y, Sun B, et al. Hsa_circ_0001479 accelerates tumorigenesis of gastric cancer and mediates immune escape. Int Immunopharmacol. 2023;124:110887. https:\/\/doi.org\/10.1016\/j.intimp.2023.110887.","journal-title":"Int Immunopharmacol"},{"key":"2467_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102004","volume":"48","author":"R Jiang","year":"2024","unstructured":"Jiang R, Li P, Meng E, Cheng X, Wu X, Wu H. Hsa_Circ_0008035 drives immune evasion of gastric cancer via promoting EXT1-mediated nuclear translocation of PKM2. Transl Oncol. 2024;48:102004. https:\/\/doi.org\/10.1016\/j.tranon.2024.102004.","journal-title":"Transl Oncol"},{"key":"2467_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108918","volume":"111","author":"B Li","year":"2022","unstructured":"Li B, Liang L, Chen Y, Liu J, Wang Z, Mao Y, et al. Circ_0008287 promotes immune escape of gastric cancer cells through impairing microrna-548c-3p-dependent inhibition of CLIC1. Int Immunopharmacol. 2022;111:108918. https:\/\/doi.org\/10.1016\/j.intimp.2022.108918.","journal-title":"Int Immunopharmacol"},{"key":"2467_CR157","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1080\/15384101.2023.2271341","volume":"22","author":"M Yao","year":"2023","unstructured":"Yao M, Mao X, Zhang Z, Xi Y, Gan H, Cui F, et al. Tumor-derived circRNA_102191 promotes gastric cancer and facilitates M2 macrophage polarization. Cell Cycle. 2023;22:2003\u201317. https:\/\/doi.org\/10.1080\/15384101.2023.2271341.","journal-title":"Cell Cycle"},{"key":"2467_CR158","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s13577-022-00739-9","volume":"35","author":"J Song","year":"2022","unstructured":"Song J, Xu X, He S, Wang N, Bai Y, Li B, et al. Exosomal hsa_circ_0017252 attenuates the development of gastric cancer via inhibiting macrophage M2 polarization. Hum Cell. 2022;35:1499\u2013511. https:\/\/doi.org\/10.1007\/s13577-022-00739-9.","journal-title":"Hum Cell"},{"key":"2467_CR159","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13046-022-02499-8","volume":"41","author":"S Qiu","year":"2022","unstructured":"Qiu S, Xie L, Lu C, Gu C, Xia Y, Lv J, et al. Gastric cancer-derived exosomal miR-519a-3p promotes liver metastasis by inducing intrahepatic M2-like macrophage-mediated angiogenesis. J Exp Clin Cancer Res CR. 2022;41:296. https:\/\/doi.org\/10.1186\/s13046-022-02499-8.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"2467_CR160","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70037","volume":"6","author":"Z Zhao","year":"2025","unstructured":"Zhao Z, Sun H, Liu Y, Zhang Y, Wang X, Wang X, et al. PDPN\u2009+\u2009cancer-associated fibroblasts enhance gastric cancer angiogenesis via AKT\/NF-\u03baB activation and the CCL2-ACKR1 axis. MedComm. 2025;6:e70037. https:\/\/doi.org\/10.1002\/mco2.70037.","journal-title":"MedComm"},{"key":"2467_CR161","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s10120-022-01279-9","volume":"25","author":"L He","year":"2022","unstructured":"He L, Feng A, Guo H, Huang H, Deng Q, Zhao E, Yang M. LRG1 mediated by ATF3 promotes growth and angiogenesis of gastric cancer by regulating the SRC\/STAT3\/VEGFA pathway, gastric cancer off. J. Int. gastric cancer assoc. Jpn Gastric Cancer Assoc. 2022;25:527\u201341. https:\/\/doi.org\/10.1007\/s10120-022-01279-9.","journal-title":"Jpn Gastric Cancer Assoc"},{"key":"2467_CR162","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1007\/s10120-020-01080-6","volume":"23","author":"T Pan","year":"2020","unstructured":"Pan T, Jin Z, Yu Z, Wu X, Chang X, Fan Z, et al. Cathepsin L promotes angiogenesis by regulating the CDP\/Cux\/VEGF-D pathway in human gastric cancer. Gastric Cancer. 2020;23:974\u201387. https:\/\/doi.org\/10.1007\/s10120-020-01080-6.","journal-title":"Gastric Cancer"},{"key":"2467_CR163","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12943-020-01208-3","volume":"19","author":"M Xie","year":"2020","unstructured":"Xie M, Yu T, Jing X, Ma L, Fan Y, Yang F, Ma P, Jiang H, Wu X, Shu Y, Xu T. Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p\/HUR\/VEGF axis and suppressing HSP90 degradation. Mol Cancer. 2020;19:112. https:\/\/doi.org\/10.1186\/s12943-020-01208-3.","journal-title":"Mol Cancer"},{"key":"2467_CR164","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bbrc.2021.04.099","volume":"560","author":"S Li","year":"2021","unstructured":"Li S, Li J, Zhang H, Zhang Y, Wang X, Yang H, et al. Gastric cancer derived exosomes mediate the delivery of circRNA to promote angiogenesis by targeting miR-29a\/VEGF axis in endothelial cells. Biochem Biophys Res Commun. 2021;560:37\u201344. https:\/\/doi.org\/10.1016\/j.bbrc.2021.04.099.","journal-title":"Biochem Biophys Res Commun"},{"key":"2467_CR165","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1111\/cas.15351","volume":"113","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Zhang Q, Liao B, Qiu X, Hu S, Xu Q. Circ_0006089 promotes gastric cancer growth, metastasis, glycolysis, and angiogenesis by regulating miR-361-3p\/TGFB1. Cancer Sci. 2022;113:2044\u201355. https:\/\/doi.org\/10.1111\/cas.15351.","journal-title":"Cancer Sci"},{"key":"2467_CR166","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1080\/15384101.2022.2087280","volume":"21","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Sun C, Zheng Y, Gong Y. Circfcho2 promotes gastric cancer progression by activating the JAK1\/STAT3 pathway via sponging miR-194-5p. Cell Cycle. 2022;21:2145\u201364. https:\/\/doi.org\/10.1080\/15384101.2022.2087280.","journal-title":"Cell Cycle"},{"key":"2467_CR167","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.canlet.2021.11.031","volume":"526","author":"Y Du","year":"2022","unstructured":"Du Y, Zhang J-Y, Gong L-P, Feng Z-Y, Wang D, Pan Y-H, et al. Hypoxia-induced EBV-circLMP2A promotes angiogenesis in EBV-associated gastric carcinoma through the KHSRP\/VHL\/HIF1\u03b1\/VEGFA pathway. Cancer Lett. 2022;526:259\u201372. https:\/\/doi.org\/10.1016\/j.canlet.2021.11.031.","journal-title":"Cancer Lett"},{"key":"2467_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2022.105454","volume":"85","author":"P Li","year":"2022","unstructured":"Li P, Xiao W. Circ_0005758 impedes gastric cancer progression through miR-1229-3p\/GCNT4 feedback loop. Toxicol In Vitro. 2022;85:105454. https:\/\/doi.org\/10.1016\/j.tiv.2022.105454.","journal-title":"Toxicol In Vitro"},{"key":"2467_CR169","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1038\/s41388-024-03099-w","volume":"43","author":"P Ding","year":"2024","unstructured":"Ding P, Wu H, Wu J, Li T, He J, Ju Y, Liu Y, Li F, Deng H, Gu R, Zhang L, Guo H, Tian Y, Yang P, Meng N, Li X, Guo Z, Meng L, Zhao Q. N6-methyladenosine modified circPAK2 promotes lymph node metastasis via targeting IGF2BPs\/VEGFA signaling in gastric cancer. Oncogene. 2024;43:2548\u201363. https:\/\/doi.org\/10.1038\/s41388-024-03099-w.","journal-title":"Oncogene"},{"key":"2467_CR170","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s10528-021-10120-4","volume":"60","author":"Y Shao","year":"2022","unstructured":"Shao Y, Li F, Liu H. Circ-DONSON facilitates the malignant progression of gastric cancer depending on the regulation of miR-149-5p\/LDHA axis. Biochem Genet. 2022;60:640\u201355. https:\/\/doi.org\/10.1007\/s10528-021-10120-4.","journal-title":"Biochem Genet"},{"key":"2467_CR171","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s10528-021-10180-6","volume":"60","author":"C Liu","year":"2022","unstructured":"Liu C, Yang J, Zhu F, Zhao Z, Gao L. Exosomal circ_0001190 regulates the progression of gastric cancer via miR-586\/SOSTDC1 axis. Biochem Genet. 2022;60:1895\u2013913. https:\/\/doi.org\/10.1007\/s10528-021-10180-6.","journal-title":"Biochem Genet"},{"key":"2467_CR172","doi-asserted-by":"publisher","first-page":"795","DOI":"10.5152\/tjg.2024.23341","volume":"35","author":"Y Chen","year":"2024","unstructured":"Chen Y, Bian W, Chen S. Circ_0008035 promotes gastric cancer development via the miR-429\/SMAD2 cascade. Turk J Gastroenterol. 2024;35:795\u2013804. https:\/\/doi.org\/10.5152\/tjg.2024.23341.","journal-title":"Turk J Gastroenterol"},{"key":"2467_CR173","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1038\/s41416-020-0836-4","volume":"122","author":"H-T Liu","year":"2020","unstructured":"Liu H-T, Ma R-R, Lv B-B, Zhang H, Shi D-B, Guo X-Y, Zhang G-H, Gao P. LncRNA-HNF1A-AS1 functions as a competing endogenous RNA to activate PI3K\/AKT signalling pathway by sponging miR-30b-3p in gastric cancer. Br J Cancer. 2020;122:1825\u201336. https:\/\/doi.org\/10.1038\/s41416-020-0836-4.","journal-title":"Br J Cancer"},{"key":"2467_CR174","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2017.02.035","volume":"395","author":"Y Li","year":"2017","unstructured":"Li Y, Wu Z, Yuan J, Sun L, Lin L, Huang N, Bin J, Liao Y, Liao W. Long non-coding RNA MALAT1 promotes gastric cancer tumorigenicity and metastasis by regulating vasculogenic mimicry and angiogenesis. Cancer Lett. 2017;395:31\u201344. https:\/\/doi.org\/10.1016\/j.canlet.2017.02.035.","journal-title":"Cancer Lett"},{"key":"2467_CR175","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1038\/s41388-018-0250-z","volume":"37","author":"J Zhao","year":"2018","unstructured":"Zhao J, Du P, Cui P, Qin Y, Hu C, Wu J, Zhou Z, Zhang W, Qin L, Huang G. LncRNA PVT1 promotes angiogenesis via activating the STAT3\/VEGFA axis in gastric cancer. Oncogene. 2018;37:4094\u2013109. https:\/\/doi.org\/10.1038\/s41388-018-0250-z.","journal-title":"Oncogene"},{"key":"2467_CR176","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/1878-0261.12911","volume":"15","author":"F Teng","year":"2021","unstructured":"Teng F, Zhang J-X, Chen Y, Shen X-D, Su C, Guo Y-J, et al. LncRNA NKX2-1-AS1 promotes tumor progression and angiogenesis via upregulation of SERPINE1 expression and activation of the VEGFR-2 signaling pathway in gastric cancer. Mol Oncol. 2021;15:1234\u201355. https:\/\/doi.org\/10.1002\/1878-0261.12911.","journal-title":"Mol Oncol"},{"key":"2467_CR177","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.705697","volume":"9","author":"Y Xu","year":"2021","unstructured":"Xu Y, Li Y, Qiu Y, Sun F, Zhu G, Sun J, et al. LncRNA NEAT1 promotes gastric cancer progression through miR-17-5p\/TGF\u03b2R2 axis up-regulated angiogenesis. Front Cell Dev Biol. 2021;9:705697. https:\/\/doi.org\/10.3389\/fcell.2021.705697.","journal-title":"Front Cell Dev Biol"},{"key":"2467_CR178","doi-asserted-by":"publisher","first-page":"e14655","DOI":"10.1016\/j.heliyon.2023.e14655","volume":"9","author":"X Zhang","year":"2023","unstructured":"Zhang X, Jin M, Liu S, Zang M, Hu L, Du T, Zhang B. The roles and molecular mechanisms of long non-coding RNA WT1-AS in the maintenance and development of gastric cancer stem cells. Heliyon. 2023;9:e14655. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e14655.","journal-title":"Heliyon"},{"key":"2467_CR179","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12935-019-0799-9","volume":"19","author":"L Tang","year":"2019","unstructured":"Tang L, Wen J-B, Wen P, Li X, Gong M, Li Q. Long non-coding RNA LINC01314 represses cell migration, invasion, and angiogenesis in gastric cancer via the Wnt\/\u03b2-catenin signaling pathway by down-regulating KLK4. Cancer Cell Int. 2019;19:94. https:\/\/doi.org\/10.1186\/s12935-019-0799-9.","journal-title":"Cancer Cell Int"},{"key":"2467_CR180","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.18632\/aging.204078","volume":"14","author":"J Zhang","year":"2022","unstructured":"Zhang J, Pang X, Lei L, Zhang J, Zhang X, Chen Z, Zhu J, Jiang Y, Chen G, Wu Y, Wu T, Pan Y, Liu Y, Cui Y, Wang X. LncRNA CRART16\/miR-122-5p\/FOS axis promotes angiogenesis of gastric cancer by upregulating VEGFD expression. Aging. 2022;14:4137\u201357. https:\/\/doi.org\/10.18632\/aging.204078.","journal-title":"Aging"},{"key":"2467_CR181","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1432","volume":"13","author":"R Dou","year":"2023","unstructured":"Dou R, Han L, Yang C, Fang Y, Zheng J, Liang C, et al. Upregulation of LINC00501 by H3K27 acetylation facilitates gastric cancer metastasis through activating epithelial-mesenchymal transition and angiogenesis. Clin Transl Med. 2023;13:e1432. https:\/\/doi.org\/10.1002\/ctm2.1432.","journal-title":"Clin Transl Med"},{"key":"2467_CR182","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41577-024-01026-4","volume":"24","author":"M De Martino","year":"2024","unstructured":"De Martino M, Rathmell JC, Galluzzi L, Vanpouille-Box C. Cancer cell metabolism and antitumour immunity. Nat Rev Immunol. 2024;24:654\u201369. https:\/\/doi.org\/10.1038\/s41577-024-01026-4.","journal-title":"Nat Rev Immunol"},{"key":"2467_CR183","doi-asserted-by":"publisher","unstructured":"Mossmann D, M\u00fcller C, Park S, Ryback B, Colombi M, Ritter N, Wei\u00dfenberger D, Dazert E, Coto-Llerena M, Nuciforo S, Blukacz L, Ercan C, Jimenez V, Piscuoglio S, Bosch F, Terracciano LM, Sauer U, Heim MH, Hall MN. Arginine reprograms metabolism in liver cancer via RBM39, cell 186 (2023) 5068\u2013e508323. https:\/\/doi.org\/10.1016\/j.cell.2023.09.011","DOI":"10.1016\/j.cell.2023.09.011"},{"key":"2467_CR184","doi-asserted-by":"publisher","first-page":"4896","DOI":"10.1158\/0008-5472.CAN-21-2647","volume":"81","author":"AM Hosios","year":"2021","unstructured":"Hosios AM, Manning BD. Cancer signaling drives cancer metabolism: AKT and the Warburg effect. Cancer Res. 2021;81:4896\u20138. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-2647.","journal-title":"Cancer Res"},{"key":"2467_CR185","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/cac2.12459","volume":"43","author":"X Hu","year":"2023","unstructured":"Hu X, Ma Z, Xu B, Li S, Yao Z, Liang B, et al. Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2-positive gastric cancer. Cancer Commun. 2023;43:909\u201337. https:\/\/doi.org\/10.1002\/cac2.12459.","journal-title":"Cancer Commun"},{"key":"2467_CR186","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216841","volume":"593","author":"L Wang","year":"2024","unstructured":"Wang L, Mao X, Yu X, Su J, Li Z, Chen Z, et al. FPR3 reprograms glycolytic metabolism and stemness in gastric cancer via calcium-NFATc1 pathway. Cancer Lett. 2024;593:216841. https:\/\/doi.org\/10.1016\/j.canlet.2024.216841.","journal-title":"Cancer Lett"},{"key":"2467_CR187","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113978","volume":"148","author":"W Jiang","year":"2025","unstructured":"Jiang W, Yin F, Bian X, Wang Z, Zhang C. The mechanism study of LncRNA AC012181.2 targeting HERPUD1 protein in regulating stromal stem cells participating in metabolic reprogramming for gastric cancer metastasis. Int Immunopharmacol. 2025;148:113978. https:\/\/doi.org\/10.1016\/j.intimp.2024.113978.","journal-title":"Int Immunopharmacol"},{"key":"2467_CR188","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12943-018-0935-5","volume":"18","author":"X Zhang","year":"2019","unstructured":"Zhang X, Wang S, Wang H, Cao J, Huang X, Chen Z, Xu P, Sun G, Xu J, Lv J, Xu Z. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1\/mTOR pathway. Mol Cancer. 2019;18:20. https:\/\/doi.org\/10.1186\/s12943-018-0935-5.","journal-title":"Mol Cancer"},{"key":"2467_CR189","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-020-01791-9","volume":"40","author":"J Cao","year":"2021","unstructured":"Cao J, Zhang X, Xu P, Wang H, Wang S, Zhang L, et al. Circular RNA circLMO7 acts as a microRNA-30a-3p sponge to promote gastric cancer progression via the WNT2\/\u03b2-catenin pathway. J Exp Clin Cancer Res. 2021;40:6. https:\/\/doi.org\/10.1186\/s13046-020-01791-9.","journal-title":"J Exp Clin Cancer Res"},{"key":"2467_CR190","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12967-022-03286-x","volume":"20","author":"H Liu","year":"2022","unstructured":"Liu H, Xue Q, Cai H, Jiang X, Cao G, Chen T, Chen Y, Wang D. RUNX3-mediated circDYRK1A inhibits glutamine metabolism in gastric cancer by up-regulating microRNA-889-3p-dependent FBXO4. J Transl Med. 2022;20:120. https:\/\/doi.org\/10.1186\/s12967-022-03286-x.","journal-title":"J Transl Med"},{"key":"2467_CR191","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1021\/acs.jproteome.3c00476","volume":"22","author":"S Chu","year":"2023","unstructured":"Chu S, Fei B, Yu M. Molecular mechanism of circ_0088300-BOLL interaction regulating mitochondrial metabolic reprogramming and involved in gastric cancer growth and metastasis. J Proteome Res. 2023;22:3793\u2013810. https:\/\/doi.org\/10.1021\/acs.jproteome.3c00476.","journal-title":"J Proteome Res"},{"key":"2467_CR192","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10735-021-10044-8","volume":"53","author":"L Zheng","year":"2022","unstructured":"Zheng L, Yan B, Jin G, Han W, Wang H, Wang Z, Ma Y, Nian Y, Meng X, Jiang Z. Circ_0003159 upregulates LIFR expression through competitively binding to miR-221-3p\/miR-222-3p to block gastric cancer development. J Mol Histol. 2022;53:173\u201386. https:\/\/doi.org\/10.1007\/s10735-021-10044-8.","journal-title":"J Mol Histol"},{"key":"2467_CR193","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/s41419-021-04216-3","volume":"12","author":"J Yang","year":"2021","unstructured":"Yang J, Zhang X, Cao J, Xu P, Chen Z, Wang S, et al. Circular RNA UBE2Q2 promotes malignant progression of gastric cancer by regulating signal transducer and activator of transcription 3-mediated autophagy and glycolysis. Cell Death Dis. 2021;12:910. https:\/\/doi.org\/10.1038\/s41419-021-04216-3.","journal-title":"Cell Death Dis"},{"key":"2467_CR194","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41419-024-06607-8","volume":"15","author":"Z-H Wu","year":"2024","unstructured":"Wu Z-H, Wang Y-X, Song J-J, Zhao L-Q, Zhai Y-J, Liu Y-F, Guo W-J. LncRNA SNHG26 promotes gastric cancer progression and metastasis by inducing c-Myc protein translation and an energy metabolism positive feedback loop. Cell Death Dis. 2024;15:236. https:\/\/doi.org\/10.1038\/s41419-024-06607-8.","journal-title":"Cell Death Dis"},{"key":"2467_CR195","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1088","volume":"12","author":"T Dai","year":"2022","unstructured":"Dai T, Zhang X, Zhou X, Hu X, Huang X, Xing F, et al. Long non-coding RNA VAL facilitates PKM2 enzymatic activity to promote Glycolysis and malignancy of gastric cancer. Clin Transl Med. 2022;12:e1088. https:\/\/doi.org\/10.1002\/ctm2.1088.","journal-title":"Clin Transl Med"},{"key":"2467_CR196","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/carcin\/bgad080","volume":"45","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Gao Y, Li F, Qi Q, Li Q, Gu Y, Zheng Z, Hu B, Wang T, Zhang E, Xu H, Liu L, Tian T, Jin G, Yan C. Long non-coding RNA NRAV in the 12q24.31 risk locus drives gastric cancer development through glucose metabolism reprogramming. Carcinogenesis. 2024;45:23\u201334. https:\/\/doi.org\/10.1093\/carcin\/bgad080.","journal-title":"Carcinogenesis"},{"key":"2467_CR197","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02827-6","volume":"42","author":"C Zhang","year":"2023","unstructured":"Zhang C, Wang H, Liu Q, Dai S, Tian G, Wei X, et al. LncRNA CCAT1 facilitates the progression of gastric cancer via PTBP1-mediated glycolysis enhancement. J Exp Clin Cancer Res. 2023;42:246. https:\/\/doi.org\/10.1186\/s13046-023-02827-6.","journal-title":"J Exp Clin Cancer Res"},{"key":"2467_CR198","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0820-2","volume":"17","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Liu Y, Lin L, Huang Q, He W, Zhang S, et al. The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK\/Lin28 mediated mRNA stability of MACC1. Mol Cancer. 2018;17:69. https:\/\/doi.org\/10.1186\/s12943-018-0820-2.","journal-title":"Mol Cancer"},{"key":"2467_CR199","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s13046-022-02449-4","volume":"41","author":"Y Jia","year":"2022","unstructured":"Jia Y, Yan Q, Zheng Y, Li L, Zhang B, Chang Z, Wang Z, Tang H, Qin Y, Guan X-Y. Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun\/c-Fos\/SREBP1 axis in gastric cancer. J Exp Clin Cancer Res CR. 2022;41:287. https:\/\/doi.org\/10.1186\/s13046-022-02449-4.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"2467_CR200","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s41419-022-05436-x","volume":"13","author":"Q He","year":"2022","unstructured":"He Q, Yang C, Xiang Z, Huang G, Wu H, Chen T, Dou R, Song J, Han L, Song T, Wang S, Xiong B. LINC00924-induced fatty acid metabolic reprogramming facilitates gastric cancer peritoneal metastasis via hnRNPC-regulated alternative splicing of Mnk2. Cell Death Dis. 2022;13:987. https:\/\/doi.org\/10.1038\/s41419-022-05436-x.","journal-title":"Cell Death Dis"},{"key":"2467_CR201","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41419-023-06049-8","volume":"14","author":"L Fang","year":"2023","unstructured":"Fang L, Huang H, Lv J, Chen Z, Lu C, Jiang T, et al. M5C-methylated lncRNA NR_033928 promotes gastric cancer proliferation by stabilizing GLS mRNA to promote glutamine metabolism reprogramming. Cell Death Dis. 2023;14:520. https:\/\/doi.org\/10.1038\/s41419-023-06049-8.","journal-title":"Cell Death Dis"},{"key":"2467_CR202","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.cell.2022.03.044","volume":"185","author":"L Qu","year":"2022","unstructured":"Qu L, Yi Z, Shen Y, Lin L, Chen F, Xu Y, Wu Z, Tang H, Zhang X, Tian F, Wang C, Xiao X, Dong X, Guo L, Lu S, Yang C, Tang C, Yang Y, Yu W, Wang J, Zhou Y, Huang Q, Yisimayi A, Liu S, Huang W, Cao Y, Wang Y, Zhou Z, Peng X, Wang J, Xie XS, Wei W. Circular RNA vaccines against SARS-CoV-2 and emerging variants. Cell. 2022;185:1728\u2013e174416. https:\/\/doi.org\/10.1016\/j.cell.2022.03.044.","journal-title":"Cell"},{"key":"2467_CR203","doi-asserted-by":"publisher","first-page":"8932","DOI":"10.1038\/s41467-024-53242-0","volume":"15","author":"X Liu","year":"2024","unstructured":"Liu X, Li Z, Li X, Wu W, Jiang H, Zheng Y, Zhou J, Ye X, Lu J, Wang W, Yu L, Li Y, Qu L, Wang J, Li F, Chen L, Wu L, Feng L. A single-dose circular RNA vaccine prevents Zika virus infection without enhancing dengue severity in mice. Nat Commun. 2024;15:8932. https:\/\/doi.org\/10.1038\/s41467-024-53242-0.","journal-title":"Nat Commun"},{"key":"2467_CR204","doi-asserted-by":"publisher","first-page":"6422","DOI":"10.7150\/thno.77350","volume":"12","author":"H Li","year":"2022","unstructured":"Li H, Peng K, Yang K, Ma W, Qi S, Yu X, He J, Lin X, Yu G. Circular RNA cancer vaccines drive immunity in hard-to-treat malignancies. Theranostics. 2022;12:6422\u201336. https:\/\/doi.org\/10.7150\/thno.77350.","journal-title":"Theranostics"},{"key":"2467_CR205","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.7150\/thno.104698","volume":"15","author":"H Yu","year":"2025","unstructured":"Yu H, Wen Y, Yu W, Lu L, Yang Y, Liu C, Hu Z, Fang Z, Huang S. Optimized circular RNA vaccines for superior cancer immunotherapy. Theranostics. 2025;15:1420\u201338. https:\/\/doi.org\/10.7150\/thno.104698.","journal-title":"Theranostics"},{"key":"2467_CR206","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/j.ymthe.2024.04.028","volume":"32","author":"J Zhou","year":"2024","unstructured":"Zhou J, Ye T, Yang Y, Li E, Zhang K, Wang Y, et al. Circular RNA vaccines against Monkeypox virus provide potent protection against vaccinia virus infection in mice. Mol Ther. 2024;32:1779\u201389. https:\/\/doi.org\/10.1016\/j.ymthe.2024.04.028.","journal-title":"Mol Ther"},{"key":"2467_CR207","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.667","volume":"5","author":"F Wang","year":"2024","unstructured":"Wang F, Cai G, Wang Y, Zhuang Q, Cai Z, Li Y, et al. Circular RNA-based neoantigen vaccine for hepatocellular carcinoma immunotherapy. MedComm. 2024;5:e667. https:\/\/doi.org\/10.1002\/mco2.667.","journal-title":"MedComm"},{"key":"2467_CR208","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02261-6","volume":"24","author":"X Song","year":"2025","unstructured":"Song X, Wei Z, Zhang C, Han D, Liu J, Song Y, et al. Circakt3 promotes prostate cancer proliferation and metastasis by enhancing the binding of RPS27A and RPL11. Mol Cancer. 2025;24:53. https:\/\/doi.org\/10.1186\/s12943-025-02261-6.","journal-title":"Mol Cancer"},{"key":"2467_CR209","doi-asserted-by":"publisher","first-page":"e2400307","DOI":"10.1002\/adma.202400307","volume":"36","author":"S Xu","year":"2024","unstructured":"Xu S, Xu Y, Solek NC, Chen J, Gong F, Varley AJ, Golubovic A, Pan A, Dong S, Zheng G, Li B. Tumor-Tailored ionizable lipid nanoparticles facilitate IL-12 circular RNA delivery for enhanced lung cancer immunotherapy. Adv Mater Deerfield Beach Fla. 2024;36:e2400307. https:\/\/doi.org\/10.1002\/adma.202400307.","journal-title":"Adv Mater Deerfield Beach Fla"},{"key":"2467_CR210","doi-asserted-by":"publisher","first-page":"e2402329","DOI":"10.1002\/advs.202402329","volume":"11","author":"RX Chen","year":"2024","unstructured":"Chen RX, Liu SC, Kan XC, Wang YR, Wang JF, Wang TL, Li C, Jiang WJ, Chen YAL, Zhou T, Fan SL, Chang J, Xu X, Shi KH, Zhang YD, Wu MY, Yu Y, Li CX, Li XC. CircUGP2 suppresses intrahepatic cholangiocarcinoma progression via p53 signaling through interacting with PURB to regulate ADGRB1 transcription and sponging miR-3191-5p. Adv Sci Weinh Baden-Wurtt Ger. 2024;11:e2402329. https:\/\/doi.org\/10.1002\/advs.202402329.","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"2467_CR211","unstructured":"Song E. A Single Arm Clinical Study of Dendritic Cell Vaccine Loaded With Circular RNA Encoding Cryptic Peptide for Patients With HER2-negative Advanced Breast Cancer, clinicaltrials.gov, 2024. https:\/\/clinicaltrials.gov\/study\/NCT06530082 (accessed March 14, 2025)."},{"key":"2467_CR212","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00262-024-03924-x","volume":"74","author":"Z Cai","year":"2025","unstructured":"Cai Z, Wuri Q, Song Y, Qu X, Hu H, Cao S, Wu H, Wu J, Wang C, Yu X, Kong W, Zhang H. CircRNA-loaded DC vaccine in combination with low-dose gemcitabine induced potent anti-tumor immunity in pancreatic cancer model. Cancer Immunol Immunother CII. 2025;74:68. https:\/\/doi.org\/10.1007\/s00262-024-03924-x.","journal-title":"Cancer Immunol Immunother CII"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02467-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02467-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02467-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:41:11Z","timestamp":1759491671000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-025-02467-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":212,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2467"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02467-8","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"244"}}